An Open Clinical Study on Kalladaippu (Urolithiasis) with the Evaluation of Siddha Drug Vediyuppu Chendooram by Govindammal, P
  
                                                 AN OPEN CLINICAL STUDY ON 
                      KALLADAIPPU (UROLITHIASIS) 
                             WITH THE EVALUATION OF SIDDHA DRUG 
                      VEDIYUPPU CHENDOORAM 
             The dissertation submitted by 
         Dr. P.GOVINDAMMAL (Reg. No. 321311101) 
 
                                               Under the Guidance of 
                                Prof. Dr. P.PARTHIBHAN, M.D.(S) 
 
              Submitted to 
                   THE TAMIL NADU DR. M.G.R. MEDICAL UNIVERSITY 
 
                                     In partial fulfilment of the requirements 
                                           For the award of the degree of 
 
                                SIDDHA MARUTHUVA PERARIGNAR 
                                   DOCTOR OF MEDICINE (SIDDHA) 
                                         BRANCH I – MARUTHUVAM 
                                                
                    POST GRADUATE DEPARTMENT OF MARUTHUVAM 
                    THE GOVERNMENT SIDDHA MEDICAL COLLEGE 
                                              CHENNAI – 106 
   OCTOBER - 2016 
                                             CERTIFICATE                                                                                                                                                                                                                                                                                                      
 
This is to certify that the dissertation entitled “AN OPEN CLINICAL  STUDY 
ON KALLADAIPPU” is a bonafide work done by Dr.P.GOVINDAMMAL, 
Government Siddha Medical College, Chennai – 600 106 in partial fulfilment of the 
University rules and regulations for award of SIDDHA MARUTHUVA 
PERARIGNAR under my guidance and supervision during the academic year 2013 – 
2016. 
 
 
 
Name & Signature of the Guide 
 
 
 
 
Name & Signature of the Head of Department 
 
 
 
 
Name & Signature of the Dean/ Principal 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
     
     Acknowledgement 
           
 
 
 
  
              ACKNOWLEDGEMENT 
I first of all express my elegance to Almighty God. 
I am extremely grateful to the siddhars for their blessings to me to complete this 
dissertation work successfully. 
 I extend my cordial thanks to Prof. Dr. P. Parthibhan M.D.(S), Joint director,  As well 
as my guide, for his valuable guidance, useful support and kind opinions throughout this study. 
I am grateful to thank Dr. K. Kanakavalli, M.D.(S), Principal, Govt. Siddha Medical 
College, Chennai – 106, for her encouragement given during the course of this study. 
 I am very glad to thank Prof. Dr.N.Anbu, M.D.(S), H.O.D, department of Maruthuvam, 
Govt. Siddha Medical College, Chennai – 106, for his valuable suggestions during my study. 
I wish to express my thanks to Dr. R.  Menaka, M.D.(S) for her useful support and 
constant encouragement during the course of this study. 
I also extend my thanks to Dr. U. Chithra, M.D.(S), for her kind opinions in this 
dissertation work. 
I am very glad to thank Dr. R. Sasirekha, M.D.(S), for her kind opinions in this 
dissertation work. 
I wish to express my sincere thanks to DR. S. M. Chitra, M.D.(S), for kind opinions in 
this dissertation work. 
I wish to thank Dr. Vidhya M.B.B.S., D.M.R.D., Sonologist, Arignar Anna Govt. 
Hospital of Indian Medicine, Chennai-106. 
 
            I also convey my sincere thanks to Dr. P. MURALI DHARAN, M.pharm, Ph.D. Asst. 
Prof. Baid metha College of Pharmacy for doing my preclinical studies of my trial medicine. 
  
I also convey my sincere thanks to Mrs.S. shakila, research officer, central siddha 
research institute,  Chennai-106  for doing my physico chemical analysis for my trial medicine. 
 
I like to thank, Prof. S. Selvaraj, M.Sc, M.Phil, HOD, Department of Biochemistry, 
Government Siddha Medical College, Arumbakkam – 106 for my biochemical analysis. 
 
I deeply convey my gratitude to Dr. Sathiya Rajeswaran, M.D(S), R.O., C.C.R.S., 
Chennai-106 for his moral and timely support during my work. 
 
I also convey my special thanks to Dr. Manivasagam, B.S.M.S, M.Sc. Biostatistics and 
epidemiology, for the part in Bio-statistical analysis of my results. 
I would like to thank my senior Dr.Aaliya parveen M.D(S), for her kind help and 
support. 
I wish to thank my batch mates and friends for kind co- operation and support in my 
dissertation book 
I would like to thank all the teaching staffs of PG department, Govt. Siddha Medical 
College, Chennai – 106 for their timely suggestion and encouragement.  
           I want to thank my parients Mr.K.R.Palanisami, Mrs.P.Nallammal, and my brothers for 
all the support you’ve given me during my time here, constant motivation, valuable suggestion 
and encouragement enable me to complete this dissertation with perfection. 
          Last and most importantly, I am indebited to all my patients for willingly accepting 
themselves for this study. 
 . 
 
 
 
 
  
 
 
 
 
 
         CONTENTS 
 
 
 
 
 
 
 
 
 
 
                                                 
 
                                        CONTENTS 
S.No TITLE PAGE.No 
1 INTRODUCTION 1 
2 AIM AND OBJECTIVES 5 
3 REVIEW OF LITERATURE 7 
  SIDDHA ASPECT 8 
  MODERN ASPECT 34 
  TRIAL DRUG 67 
4 MATERIALS AND METHODS 72 
5 RESULTS AND OBSERVATION 75 
6 DISCUSSION 110 
7 SUMMARY 116 
8 CONCLUSION 118 
9 ANNEXURES  
 I. CERTIFICATES 120 
 II. BIO CHEMICAL ANALYSIS 129 
 III. PHYSICO CHEMICAL 
ANALYSIS 
134 
 IV. TOXICOLOGICAL STUDY 136 
 V. PHARMACOLOGICAL STUDY 147 
 VI. BIO STATISTICAL ANALYSIS 154 
 VII. CONSENT FORM 157 
 VIII. CASE SHEET PROFORMA 160 
10 BIBLIOGRAPHY 169 
 
 
1 
 
 
 
 
 
 
   INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
2 
 
INTRODUCTION 
 
                         
                        
                         
                       1 
                                
Siddha system is a traditional medical system of south India. The art of healing 
incorporates a variety of holistic practices and remedies which were established by the  
Siddhars, out of their intuitions. Hence it is named as Siddha Medicine. 
According to siddha theory the human body is made by  96 thathuvam on the 
principle of  panjapootham and thridhosam. Siddhars used thiridhosam- panjapootham-
arusuvai relativity to cure the disease.siddhars used herbs,metals minerals as their 
ingredients in their prepartion
2
.                
Yugi munivar spread this  knowledge to human beings for the welfare of their 
wellbeing.This has been quoted by yugi munivar by the following lines,   
                                       
                           
                                        
                         
                                       ”3 
        As per siddha aspect, the physiological function of the human body is maintained by 
three thodams called as vatham, pitham and kabam. The normal proportion of naadi is 
1:1/2:1/4 respectively, any change in this proportion leads to many diseases.                                         
Siddhars classified 4,448 types of disease. Within that kalladaippu is one of the 
disease commonly affecting men than women. 
(4) 
 
3 
 
Even though many siddhars explain about diseases, Yugi in his “YUGI 
VAIDHYA CHINTHAMANI 800” elaborately said the aetiology, pathology, 
classification, clinical features, and prognosis of kalladaippu. The diseases of urinary 
system are divided into two types, They are, 
       “               
                      ” 
The kalladaippu comes under the classification of “              ”  
which  produces low urine output and dries up the urine and form urinary calculi , due to 
various aetiological factors.
5
 
Nephrolithiasis or urolithiasis is formation of urinary calculi at any level of the 
urinary tract. Urinary calculi are worldwide in distribution but are particularly common in 
some geographic locations such as in parts of the United States, South   Africa, India and 
South- East Asia. It is estimated that approximately 2% of the population experiences 
renal stone disease at some time in their life with male- female ratio of 2:1. The peak 
incidence is observed in   2nd to 3
rd
 decades of life. Renal calculi are characterized 
clinically by colicky pain.
6 
                              
                  ”7 
 As per Thiruvalluvar says, a good physician must find out the disease with its root 
cause and cure it with the help of his diagnostic tools.  
     In our system,  there  are  many drugs  indicated  for  kalladaippu   disease.             
THIRUMOOLAR  Says   about  the  siddha  medicines  as  follows: 
      “                             
                          
                      
                          3 
4 
 
 The vediyuppu chendooram has been selected for the clinical study to prove the 
efficacy of the medicine in kalladaippu. A proper dosage, anupanam  and pathiyam were 
also followed to get good prognosis and to prove the efficacy of the trial drug in this 
disease. 
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                                              AIM 
   To study the efficacy of the siddha medicine veddiyuppu chendooram both clinically 
and experimentally for kalladaippu. 
   
                                 OBJECTIVES  
 To study the evaluation of siddha trial drug  vediyuppu chendooram for 
kalladaippu 
 To evaluate the safety profile of the trial drug. 
 To collect the literature of the both siddha and modern aspect related to the 
disease. 
 To study the disease with deep observation on aetiology, classification, pathology, 
diagnosis, differential diagnosis, prognosis and treatment by siddha aspect. 
 To gather the diagnostic knowledge by mukutram, udal thathukkal, uyir 
thathukkal, and en vakai thervugal. 
 To make a clinical observation about the disease in relation of age, sex, 
occupation, socio economic status. 
 To use modern parameters to confirm the disease. 
 To evaluate   
 Toxicological analysis-acute and subacute study 
 physico chemical analysis 
 pharmacological analysis –lithotriptic activity and 
 biostatisical analysis of the trial drug. 
  The haematological analysis, urine analysis, ultra sonogram radiological studies                                    
will be done to all patients. 
 All patients are subjected to thorough investigation before and after treatment. 
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 REVIEW OF LITERATURE 
SIDDHA  ASPECT  
Theran karisal says, 
 The diseases of the urinary system are divided into two types. They are  
“               
                      ”5 
The disease kalladaippu comes under the classification of “Neerinai Arukkal 
Noi”. In siddha system of medicine, the disease kalladaippu is mentioned by Yugi 
Munivar in Yugi Vaidhya Chinthamani 800. 
“                                  
                                  
                               ”9 
                           
   KALLADAIPPU NOI 
VERUPEYAR (SYNONYMS) 
 Achmari 
IYAL (DEFINITION) 
 Sudden obstruction in the flow of urine, pain at the tip of the penis in males and 
clitoris in females, burning micturition, loin to groin pain, passing of small sand like 
stones along with urine are the cardinal features of this disease. 
10
 
Dehydration occurs due to overheat of the body. It leads to solid or crystalline 
aggregation from the dietary minerals in the kidney. The formed stone cannot expelled by 
kidnys leads to this diseased condition.
11
                                          
 
 
10 
 
 Large concretions of stone in the bladder or kidney are known as calculus or gravel. 
 It is attended with difficulty in passing urine.
12
 Sudden obstruction to the flow of urine, 
pain at the tip of the penis in males and clitoris in females, burning micturition, pain in 
loin to groin region.
13
 
                          
                          
                         
                       .14 
            
                                   
                           
                                       
                          
                                    
                           
                                      
                       15. 
    
        “                         
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                                   ” 15 
 
If a stone present in the bladder, there will be frequency of Micturition.when the 
stone descends to urethra there will be obstruction of urine flow. It is cured through 
catheterization. 
 
  NOI VARUM VAZHI (AETIOLOGY) 
 
“                              
                           
                            
                           
                             
                            
“                        
                         ” 
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                               .”16 
             
    The urine constituents will easily deposit on the urinary tract and form the stone. At 
that time by vitiation of vatham and pitham these small stone becomes larger in size and 
block the urinary passage. The semen will stagnate for a long time in the urinary tract, so 
it will obstruct the urine flow Urinary stone are also formed due to the drinking of 
contaminated hard water, taking of food mixed with sand and small stones consuming of 
contaminated food articles, food containing more carbohydrates, unhealthy food habits
.
 
 
A urinary disease occasionally developed in the urinary bladder which is known 
as vesical calculus. It is said to be due to the deranged vayu encircling or prevailing in the 
region of the abdomen arising from any of the following causes. 
1) Suppression of seminal discharge during sexual intercourse. 
2) Retention of semen in the spermatic region in involuntary discharge during 
nocturnal emissions due to excessive heat in the body. 
           The calculus are stone which is formed in the bladder may vary in size from that 
of the particles of sand or mustard upto things as large as green gram or Bengal gram and 
sometimes attains the size of a hen’s egg even and block the passage of urine. It is 
accompanied by pain and difficulty in passing urine.
 17
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                    “                  
                              
                
                   
                    
                  
                 
                 ”18 
POTHU KURIGUNANGAL (Clinical features) 
 Gradual or sudden obstruction of the urine flow. 
 Unbearable pain in the penis 
 Excruciating pain and swelling is experienced at the tip of penis if the calculus 
attempts to expel. 
 Colicky pain radiating from loin to groin lower abdomen and urethra if the 
calculus is irregular with sharp projection.  
 Burning and scanty micturition and  Haematuria.19 
CLASSIFICATION 
 Classification according to yugimamunivar, 
“                           
                          
                        
                              
                          
                          
                        
                            ” 20          
14 
 
 According to Yugi vaidhya chinthamani, kalladaippu is classified into four types. 
1) Vadha kalladaippu 
2) Piththa kalladaippu 
3) Silethuma kalladaippu 
4) Thondha kalladaippu 
       1)  Vadha kalladaippu: 
“                          
                            
                       
                                 
                            
                            
                           
                              .”20 
Acute pricking pain in the lower abdomen, scanty Micturition, obstruction to the flow of 
urine, pain in the penis, abdominal discomfort, and albuminuria will be present with 
mucous discharge and black coloured stone will be expelled. 
2)Piththa kalladaippu: 
“                        
                                 
                              
                             
                            
                               
                          
                            .” 21   
15 
 
Obstruction of urine flow, pricking pain and burning sensation in external meatus, 
expulsion of blood coloured stones. 
3)Silethuma kalladaippu: 
“                         
                             
                     
                              
                        
                                 
                         
                              ”21 
Pricking pain in umbilicus, pain in the joints of hands and legs, expulsion of white 
coloured stone in urine, excessive sweating. 
5) Thondha kalladaippu: 
“                         
                             
                         
                                       
                        
                                
                           
                                 ”22 
Severe pain in urethra, Dysuria, Oliguria, handful of small sand like stones will expel 
with severe pain.
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According to Dhanvanthri, 
“                                  
                                  
                               
                               ”23 
      
Achmari is classified into four types,  
           1) Kallerippan 
2)Silethuma achmari 
3)Piththa achmari 
4)Sukkilachmari 
1) Kallerippan gunam: 
“                                
                                              
                                    
                                       .”23 
 Formations of stones in the urinary tract, oliguria, pricking pain around the 
umbilicus, fever, anorexia are the symptoms of this type. 
2) Silethuma achmari gunam: 
                                        
                                          
                                            
                                 ” 24 
 
Oliguria due to obstruction of stone in urethral orifice, stones can be expelled out into 
pieces
. 
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3) Piththa achmari gunam: 
“                                     
                                         
                                   
                                .” 24 
Burning micturition in urethral orifice, formations of stones, severe pain are the 
symptoms 
    4)Sukkilachmari gunam:
 
“                                 
                              
                                   
                                   .”25 
Stagnation of semen leads to the formation of stones, oliguria, and expulsion of 
small sand like stones. It is fatal
. 
 SAATHIYAM, ASAATHIYAM (PROGNOSIS) 
As per yugi, 
 Vatha kalladaippu, piththa kalladaippu, silethuma kalladaippu are curable. 
Thondha kalladaippu is fatal. 
“                            
                       
                     
                       
                       
                          
                          
                          .”26 
18 
 
MUKKUTRA VAERUPADUGAL (PATHOGENESIS): 
 Disease occurs due to the derangement in 
 Uyir thathukkal 
 Udal thathukkal 
 Kalamarupadu (seasonal changes) 
 Thinai (living lands) and 
 Udal vanmai. 
Mukkutra iyal: 
 The function of the three uyir thathus: 
a) Vali – Kattru + Veli 
b) Azhal – Thee  
c) Iyyam – Neer + Mann 
The alteration of three thathu in their reaction to extrinsic or intrinsic factors 
results in disharmony. This altered harmony and balance variation of the three thathus 
results in disease. Their natural ratio (1:1/2:1/4) to each other is discerned by the 
physician at the wrist and each nadi is individually assessed for its strength, speed and 
regularity. 
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VATHAM 
 The term vatham denotes vayu, dryness, pain and flatulence. Based on functions 
and locations it is classified into ten types. They are tabulated below. 
S.No Vatham General Features Changes in 
Kalladaippu 
1 Piranan 
(Uyirkkaal) 
Responsible for respiration and it is 
necessary for proper digestion. 
Normal 
2 Abanan 
(Keel nokkukkaal) 
Responsible for all the downward forces 
such as voiding of urine, stools, semen, 
menstrual flow. 
Affected 
    (scanty Micturition) 
3 Viyanan 
(Paravukaal) 
Dwells in the skin and is concerned with 
the sense of touch, extension and flexion of 
the parts of the body and distribution of the 
nutrients to various parts of the body. 
Normal 
4 Uthanan  
(Melnokkukaal) 
Responsible for all kinds of upward motion 
such as nausea, vomiting etc., 
Affected 
    (Nausea, vomiting) 
5 Samanan 
(Nadukkaal) 
Considered essential for proper digestion, 
assimilation and carries the digested 
nutrients to each and every organ. 
Affected 
6 Nagan Helps in opening and closing of eyelids. Normal 
7 Koorman Responsible for vision, lacrimation and 
yawning. 
Normal 
8 Kirugaran Induces appetite, salivation, all secretions 
in the body including nasal secretion and 
sneezing. 
Normal 
9 Thevathaththan Induces and stimulates a person to become 
alert, get anger, to quarrel, to sleep etc., 
Normal 
10 Dhananjeyan Resides in the cranium and produces 
bloating of the body after death. This 
leaves from the body after 3 days of death, 
forming a way through the skull
27
 
Normal 
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PITHAM 
 It is the thermal life force of the body. It is sub divided into five types. They are 
 
S.No 
 
Pitham 
 
General Features 
 
Changes in 
Kalladaippu 
1 Anarpitham Peps up the appetite and aids in digestion. Normal 
2 Ranjagapitham Responsible for the colour and contents of 
blood. 
Normal 
3 Saathagapitham Controls the whole body and is held 
responsible for fulfilling a purpose. 
Affected 
(Dysuria, 
Oliguria) 
4 Pirasagapitham Dwells in the skin and concerned with the 
shine, glow, texture and its complexion. 
Normal 
5 Alosagapitham Responsible for the perception of vision.
28
 Normal 
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KABHAM 
 It is responsible for the stream line functions of the body and maintains body’s 
defence mechanism intact. It is again classified into 5 types. 
 
S.No 
 
KABHAM 
 
GENERAL FEATURES 
CHANGES IN 
KALLADAIPPU 
1 Avalambagam Lies in the respiratory organs, 
exercises authority over other kabhas 
and control the heart and circulatory 
system. 
Normal 
2 Kilethagam Found in stomach as it seat, moistens 
the food, softens and helps to be 
digested. 
Normal 
3 Pothagam Responsible for the perception of 
taste 
Normal 
4 Tharpagam Presents in the head and is 
responsible for the coolness of the 
eyes, sometimes may be referred to 
as cerebrospinal fluid. 
Normal 
5 Santhigam Necessary for the lubrication and the 
free movements of joints
.29
 
Normal 
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PARUVAKALAM 
S.No Perum pozhuthugal Mukkutra marupaadugal 
1 Kaar kaalam 
(Aavani & Purattasi) 
Mid August to Mid October 
VATHAM - Vaetrunilai valarchi 
PITHAM – Thannilai valarchi   
2 Koothir kaalam 
(Iypasi & Karthigai) 
Mid October to Mid December  
VATHAM – Thannilai adaidhal 
PITHAM - Vaetrunilai valarchi 
3 Munpani kaalam 
(Margazhi & Thai) 
Mid December to Mid February  
PITHAM – Thannilai adaidhal 
4 Pinpani kaalam 
(Masi & Panguni) 
Mid February to Mid June  
KABHAM – Thannilai valarchi 
5 Elavenir kaalam 
(Chithirai & Vaikaasi) 
Mid April to Mid June  
KABHAM – Vaetrunilai valarchi 
6 Mudhuvenir kaalam 
(Aani & Aadi) 
Mid June to Mid August  
VATHAM – Thannilai valarchi 
KABHAM – Thannilai adaidhal30 
 
 
THINAI (LAND) 
 Siddhars classified the lands into five types. They are  
1. Kurunji – Mountain range 
2. Mullai – Pastoral area of the forest 
3. Marudham – The fertile river bed 
4. Neidhal – The coastal region 
5. Paalai – Arid desert 
23 
 
Kabha diseases will occur in Kurinji land. Pitha diseases occur in Mullai land. Vadha 
diseases occur in Neidhal land. Staying in Paalai land is not good to health. Marudham 
land is the fertile area where no disease occurs. So, Marudham land is the best one to 
stay.The winter season gives good health to the man, early summer and later rainy gives 
moderate health. Whereas early rainy and later summer are more prone to diseases, that’s 
why siddhars called it as Aanaga kaalam. 
31
 
RELATION BETWEEN MUKKUTRAM, KAALANGAL AND THINAIGAL 
 
 
Mukkutram 
Paruvakaalam (Seasons)  
 
Thinai 
Thannilai 
valarchi 
(Accumulation) 
Vaetrunilai 
valarchi 
(Aggravation) 
Thannilai 
adaidhal 
(Alleviation) 
VATHAM Mudhuvenil 
kaalam 
Kaar kaalam Koothir kaalam Vatha disease is 
more prevalent in 
Neidhal land  
PITHAM Kaar kaalam Koothir kaalam Munpani kaalam Pitha disease is 
more prevalent in 
Mullai land 
KABHAM Pinpani kaalam Elavenil kaalam Mudhuvenil 
kaalam
32 
Kabha disease is 
more prevalent in 
Kurunji land
33 
 
UDAL VANMAI (IMMUNITY) 
 Siddhars classify udal vanmai into three types. They are 
1. Iyarkai vanmai 
2. Kala vanmai 
3. Seyarkai vanmai 
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UDAL KATTUGAL 
S.No Udal kattugal General Features Changes in 
Kalladaippu 
1 Saaram 
 (Digestive essence) 
Responsible for the growth and 
development. It keeps the 
individual in good temperament 
and it enriches the body. 
Affected due 
to pain 
2 Senneer (Blood) Responsible for the color of the 
blood and for the intellect, 
nourishment, strength of the body. 
Normal 
3 Oon (Muscle) Gives lookable contour to the body 
as needed for the physical activity. 
It feed the fat next day and gives a 
sort of plumpness to the body. 
Normal 
4 Kozhuppu (Fat) Lubricates the organs to facilitate 
frictionless functions. 
Normal 
5 Enbu (Bones) Supports and protects the vital 
organs, gives the definite structure 
of the body and responsible for the 
posture and movements of the 
body. 
Normal 
6 Moolai (Bone marrow) Nourishes the bone marrow and 
brain which is the centre that 
controls other system of body. 
Normal 
7 Sukkilam/Suronitham  Responsible for reproduction.
34
 Normal 
 
 
 
 
25 
 
PINIYARI MURAIMAI (DIAGNOSIS) 
   Four steps are followed in diagnosing the disease. They are 
1. Poriyaal aridhal 
2. Pulanal therdhal 
3. Vinaadhal 
4. Envagai thervugal 
PORIYAAL ARIDHAL: 
 In this, the physician should carefully observe the changes that occur in the five 
sensory organs (porigal) of the patient. 
PULANAL THERDHAL: 
 The physician carefully applies his five senses of perception, smell, taste, vision, 
touch and sound to understand the condition of the patient. 
VINAADHAL: 
 The physician should interrogate about the patients name, age, occupation, socio- 
economic status, food habits, history of past illness, history of present illness, family 
history, marital status, menstrual history and frequency of pain. 
ENVAGAI THERVUGAL: 
 “                       
                             .”35 
                  
Nowadays advanced diagnostic tools have been developed by modern bio medical 
scientists. But siddhars have given eight diagnostic methodological tools. They are called 
as Envagai thervu.
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Eight fold system of clinical assessments: 
 Siddhars have given eight diagnostic methodological tools. They are 
1. Naadi 
2. Sparisam 
3. Naa 
4. Niram 
5. Mozhi 
6. Vizhi 
7. Malam 
8. Moothiram36 
GENERAL FINDINGS: 
NAADI: 
 Naadi is responsible for the existence of life, can be felt one inch below the wrist 
on the radial side by means of palpation with tips of index, middle and ring finger, 
corresponding to vatham, pitham, kabham. 
 Three humours Vatham, Pitham, and Kabham are in the ratio 1:1/2:1/4 normally. 
Derangement in these ratio leads to various disease conditions. 
Naadi nadai in kalladaippu 
 When the vatham add with mandham it produces the kalladaippu disease. 
“                                    
                                   
                                   
                              .”37 
 
27 
 
SPARISAM: 
 By sparisam, the temperature of skin (thatpam- cold or veppam – heat), 
smoothness, roughness, sweating, dryness, hard patches, swelling, abnormal growth of 
organs and tenderness can be felt. 
 In Kalladaippu, patient feels tenderness over the lower abdomen, renal angle and 
lumbar region. Also patient’s temperature is increased in lower abdomen, sweating all 
over the body at the time of colic.  
NAA: 
 Signs and symptoms in the tongue are noted here. Colour, salivary secretion, 
ulcers, coating, inflammation, taste changes, deviation and its nature are generally noted. 
 In kalladaippu, the naa is not affected. 
NIRAM: 
 The colour of the skin is noted here. 
 In kalladaippu, the Niram may be affected in sukkila achmari. 
 
MOZHI: 
 Character of the speech is noted, mainly uraththa oli (high pitched), thazhndha oli 
(low pitched), or resembles the sound of any instrument. 
 In kalladaippu, the mozhi will be affected to the patients who have severe pain 
leading to the thazhndha oli. 
 
VIZHI: 
 Character of the eye is noted. Colour, warm, burning sensation, irritation, visual 
perception are generally noted. 
 In kalladaippu, the vizhi may be affected. Redness due to renal colic pain. 
 
MALAM: 
 The stools are examined for quantity, hardening (malakattu), loose motion 
(bedhi), colour and smell. 
 In kalladaippu, the malam will be affected due to either constipation or diarrhoea. 
28 
 
 
MOOTHIRAM 
a) NEERKURI (Urine examination) 
 Urine examination is good diagnostic method compare to naadi and other 
Envagai thervugal. Theraiyar mention it as. 
 
“                           
                          
                      
                      
                          
                        .”38 
The early morning urine sample is collected and sample should be examined 
within one and hour hours.
 
SIRUNEERIN POTHU GUNAM: 
  “                             
                                  .”38 
        The urine is examined for its Niram (colour), Eadai (Specific gravity), Nurai (Froth), 
Natram (Smell), Enjal (Deposits). In kalladaippu, the moothiram is affected due to scanty 
Micturition. 
NIRAM (COLOUR) 
     “                           
                                       .”39 
1. Yellow 
2. Red 
3. Green 
4. Black 
5. White  
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KALLADAIPPU NEERIN GUNAM (COLOUR INDICATING URINARY 
STONES) 
  
The urine colour would look like flesh washing water; this is indicated in kidney 
diseases. This is mentioned as 
  
“                           
                          
                             
                   .”40 
EADAI (SPECIFIC GRAVITY) 
 Urine, not thick is considerably healthy. This is mentioned as 
“                           
                            .”41 
 
NURAI (FROTH) 
 Urine may be frothy in nature, if it is reduced in vali, azhal and ayyam are said to 
be deranged. This is mentioned as 
 
“                        
                        
                     .”42 
   
 
 
 
30 
 
NAATRAM (SMELL) 
 Foul odour with pyuria is observed in patients with urinary lithiasis associated 
with urinary tract infection and ulcer. This is mentioned as 
“                            
                      
                       
                        
                         
                      .”41 
 
ENJAL (DEPOSITS) 
 If urine excretion look like curd water white colour and sand like deposits in urine 
indicate stones in kidney. This is mentioned as 
 
“                                    
                                
                                 
                                .”43 
 
  
 NEIKURI 
 The early morning urine of the patient is analyzed by dropping a drop of gingely 
oil on the surface of the urine sample. The accumulation, formations, changes, and 
dispersal under the sunlight without any external disturbances of the urine sample can be 
noted. 
The urine kept on the kidney tray in sun light, on non wind condition, should be 
by dropping a drop of gin oil gently with rod. If oil spread like snake, it indicates vali 
neer; a ring indicates azhal neer and float like a pearl indicates iyya neer and sinks in 
urine indicates mukkutram. 
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                       “                   
                        
                          ”.44 
 Vatha neer – The oil spreads like snake 
 Pitha neer – The oil spreads like ring 
 Kabha neer – The oil spreads like pearl 
 If the oil spreads gradually, it indicates good prognosis45 
 If the oil spreads fast or gets mixed completely with urine or sinks in urine, it 
suggests bad prognosis.
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    Since kalladaippu is due to the derangement of vatham and pitham, the Neikuri will be 
vatha or pitha neer.   
 
  MARUTHUVAM (LINE OF TREATMENT) 
 The entire siddha system of medicine consists of three great subdivisions namely, 
1) Noyillaneri (preventive) – Kaappu 
2) Noineekuneri (curative methods) – Neekkam 
3) Uramaakkumurai (strengthening methods) - Niraippu . 
 
            Noyillaneri is the special approach of the siddha system where regular dietary 
habits, early rising, physical and mental discipilinaries are all emphasized. Prevention can 
mostly save our body and soul, but modernization results in alteration of good health, 
leads to disease.  
 
Siddha system is playing major role in treating and preventing many chronic diseases. 
Likewise, herbal medicines have several phyto chemicals which exert their beneficial 
effect on urolithiasis by multiple mechanisms like, 
 Diuretic activity 
 Crystallization inhibiting activity 
 Lithotriptic activity 
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 Antimicrobial activity 
 Analgesic and anti inflammatory activity 
 Improving renal function 
 Regulates oxalate, calcium mechanisms. 
 
          The main object of treatment is to bring down the deranged mukkutrams to natural 
equilibrium by giving purgatives, which cure derangement of vatham; this is one of the 
causes for kalladaippu. 
 In Siddha system, treatment is not only removable of disease but also the 
prevention and improving the body condition after removal of disease. This is said as 
kappu, neekkam and niraippu. 
 
Fomentation: 
 An attack of renal colic may be aborted by the application of heat fomentation 
(hot water bottle or heater) to the lumbar region. Immediate treatment of loin pain or 
renal colic is bed rest. 
 
PREVENTION: 
 
1. For prophylactic purpose it is necessary to eliminate all hindrances to a free 
drainage of urine (constriction, adenoma of the prostrate etc) and to remove foci 
of infection from the teeth and tonsils. 
2. To prevent the formation of urate calculi, a diet of milk and vegetables and 
mineral water is prescribed. 
a. In the presence of oxalate calculi restrictions are imposed on foods rich in 
calcium (milk, raw eggs, potatoes) with total abstinence from chocolate, 
spinach gooseberries and carrots. 
3. A patient with phosphorus, carbonate stones is kept on a meat diet and much 
water to drink. 
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ADVICE: 
1. Patients should drink large amount of water (2 - 3 lit/day) 
2. Patient should not suppress the excretion of urine and seminal fluid. 
3. Preparation containing Vit. D must be avoided. 
4. Regarding prevention Anubhava vaidhya deva ragasiyam states that one should 
not suppress the excretion of Moothiram (urine) and Sukkilam (Seminal fluid). 
 
NOI KANIPPU VIVADHAM (DIFFERENTIAL DIAGNOSIS) 
1) Neerkattu (Anuria) 
2) Neerchurukku (Oliguria) 
3) Chottu neer (Incontinence) 
 
DO’S AND DONT’S: 
 
DO’S: 
1) Drink 2-3 litres of water per day. 
2) Dring tender coconut, barley water, lemon juice, raddish juice. 
3) The following vegetables can be taken in the diet 
Raddish  
Lady’s finger 
Plantain pith 
Mint leaves 
Bottle guard 
 
DONT’S: 
1) Avoid cabbage, cauliflower, and tomato seeds, mushroom. 
2) Avoid milk and its products. 
3) Avoid chicken, fish and other sea foods 
Avoid drinking fluoride containing water  
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MODERN ASPECT 
 
ANATOMY AND PHYSIOLOGY OF THE URINARY SYSTEM 
 
       KIDNEYS 
 
 The kidneys are a pair of excretory organs situated on the posterior abdominal 
wall, one on each side of the vertebral column, behind the peritoneum. They remove 
waste products of metabolism and excess of water and salts from the blood, and maintain 
its pH. 
 
          
 
EXTERNAL FEATURES 
 Each kidney is bean shaped. It has upper and lower poles, medial and lateral 
borders, and anterior and posterior surfaces. 
 
TWO POLES OF THE KIDNEY 
 The upper pole is broad and is in close contact with the corresponding suprarenal 
gland. The lower pole is pointed. 
 
TWO SURFACES 
 The anterior surface is said to be irregular and the posterior surface flat, but it is 
often difficult to recognize the anterior and posterior aspects of the kidney by looking at 
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the surfaces. The proper way to do this is to examine the structures present in the hilum 
as described below. 
 
TWO BORDERS 
 The lateral border is convex. The medial border is concave. Its middle part shows 
a depression, the hilus or hilum. 
 
HILUM 
 The following structures are seen in the hilum from anterior to posterior side: 1) 
The renal vein 2) the renal artery and 3) the renal pelvis, which is the expanded upper end 
of the ureter. Examination of these structures enables the anterior and posterior aspects of 
the kidney to be distinguished from each other. As the pelvis is continuous, inferiorly, 
with the ureter the superior and inferior poles of the kidney can also be distinguished by 
examing the hilum. So it is possible to determine the side to which a kidney belongs by 
examining the structures in the hilum. Commonly, one of the branches of the renal artery 
enters the hilus behind the renal pelvis, and a tributary of the renal vein may be found in 
the same plane. 
 
LOCATION 
 The kidneys occupy the Epigastric, hypochondriac, lumbar and umbilical regions. 
Vertically they extend from the upper border of twelfth thoracic vertebra to the centre of 
the body of the third lumbar vertebra. 
 The right kidney is slightly lower than the left, and the left kidney is a little nearer 
to the median plane than the right. 
  
SHAPE, SIZE, WEIGHT AND ORIENTATION 
 Each kidney is about 11cm long, 6 cm broad and 3 cm thick. The left kidney is a 
little longer and narrower than the right kidney. On an average the kidney weighs 150 g 
in males and 135 g in females. The kidneys are reddish brown in colour. 
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 The long axis of the kidney is directed downwards and laterally, so that the upper 
poles are nearer to the median plane than the lower poles. The transverse axis is directed 
laterally and backwards. 
 
CAPSULES OR COVERINGS OF KIDNEY 
 
1. The fibrous capsule: This is a thin membrane which closely invests the kidney 
and lines the renal sinus.  
2. Perirenal or perinephric fat: This is a layer of adipose tissue lying outside the 
fibrous capsule. It is thickest at the borders of the kidney and fills up the extra 
space in the renal sinus. 
3. Renal fascia: This is a fibroareolar sheath which surrounds the kidney and the 
perirenal fat called as the fascia of Gerota. It consists of an anterior layer or fascia 
of Toldt and a posterior layer or fascia of Zuckerkandl. 
4. Pararenal or paranephric body (fat): It consists of a variable amount of fat 
lying outside the renal fascia. It is more abundant posteriorly and towards the 
lower pole of the kidney. It fills up the paravertebral gutter and forms a cushion 
for the kidney. 
 
  structure 
        Naked eye examination of a coronal section of the kidney shows: a) an outer, 
reddish brown cortex; b) an inner, pale medulla; c) a space, the renal sinus. 
 
The renal medulla is made up of about 10 conical masses, called the renal 
pyramids. Their apices form the renal papillae which indent the minor calices. 
 The renal cortex is divisible into two parts: a) cortical arches or cortical lobules, 
which form caps over the bases of the pyramids; and b) renal columns, which dip in 
between the pyramids. Each pyramid along with the overlying cortical arch forms a lobe 
of the kidney. 
 The renal sinus is a space that extends into the kidney from the hilus. It contains 
a) branches of the renal artery; b) tributaries of the renal vein; and c) the renal pelvis. The 
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pelvis divides into 2 to 3 major calices, and these in their turn divide into 7 to 13 minor 
calices. Each minor calyx ends in an expansion which is indented by one or three renal 
papillae. 
 
 Histologically, each kidney is composed of one to three million uriniferous 
tubules. Each tbule consists of two parts which are embryologically distinct from each 
other. These are as follows. 
                                   
    A)  The secretory part, called the nephron, which elaborates urine. Nephron is the 
functional unit of kidney and comprises the renal corpuscle or Malphigian corpuscle and 
the renal  tubule. 
       
     B) The collecting tubule begins as a junctional tubule from the distal convoluted 
tubule. Many tubules unite together to form the ducts of Bellini which open into minor 
calices through the renal papillae. 
 
   C) Juxtaglomerular apparatus is formed at the vascular pole of glomerulus which is 
intimately related to its own ascending limb of the Henle’s loop near the distal 
convoluted tubule. 
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BLOOD SUPPLY 
 
   ARTERIAL SUPPLY 
               
           Usually there is one renal artery on each side, arising from the abdominal aorta. 
Accessory renal arteries are present in 30% of individuals; they arise commonly from the 
aorta, run parallel to the renal artery, and enter the kidney either at the hilus or at one of 
its poles. 
 At or near the hilus the renal artery divides into anterior and posterior divisions. 
Further branching of these divisions gives rise to segmental arteries each of which  
supplies one vascular segment. Five such segments are described. These are apical, 
upper, middle, lower and posterior. The segmental arteries are end arteries, so that the 
vascular segments are independent units. 
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VENOUS DRAINAGE 
 The venous end of the peritubular capillary plexus gives rise to interlobular veins 
which run along the corresponding arteries. The interlobular veins drain into the 
arcuate veins, which in their turn open into the interlobar veins. These emerge at the 
renal sinus and join to form the renal vein which drains into the inferior vena cava. 
 The venous end of the capillary plexus along the vasa recta gives rise to veins 
which drain into the arcuate veins. 
 
LYMPHATIC DRAINAGE 
 The lymphatics of the kidney drain into the lateral aortic nodes located at the level 
of origin of the renal arteries. 
 
NERVE SUPPLY 
The kidney is supplied by the renal plexus, an offshoot of the celiac plexus. It 
contains sympathetic (T10 – L1) fibres which are chiefly vasomotor. The afferent nerves 
of the kidney belong to segments T10 to T12.
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FUNCTIONS OF KIDNEYS 
 
Kidneys perform vital functions. By excreting urine, kidneys play principal role in the 
maintenance of internal environment. In addition, kidneys perform many other functions 
as described below. 
 
1.ROLE OF HOMEOSTASIS 
The primary function of kidneys is homeostasis. It is accomplished by the 
formation of urine. Kidneys are not only the excretory organs, but are also the 
regulatory organs because their major role is in homeostasis. During the formation of 
urine, kidneys regulate various activities in the body, which are concerned with 
homeostasis. 
 
41 
 
Excretion of waste products: Removal of wastes help in homeostasis. Kidneys 
excrete the unwanted waste products which are formed during metabolic activities. 
a. Urea – end product of amino acid metabolism 
b. Uric acid – end product of nucleic acid metabolism 
c. Creatinine – end product of metabolism in muscles 
d. Bilirubin – end product of hemoglobin degradation 
e. Products of metabolism of other substances. 
Kidneys also excrete harmful foreign chemical substances like: 
a. Toxins 
b. Drugs 
c. Heavy metals 
d. Pesticides etc., 
 
Maintenance of water balance: Kidneys maintain the water balance in the body by 
conserving water when it is decreased and excreting water when it is excess in the 
body. This is a very important process for homeostasis. 
 
Maintenance of electrolyte balance: Maintenance of electrolyte balance, especially 
sodium is in relation to water balance. Kidneys retain sodium if the osmolarity of 
body water decreases and eliminate sodium when osmolarity increases. 
 
Maintenance of acid base balance: The pH of the blood and body fluids should be 
maintained within narrow range for healthy living. It is achieved by role of kidneys. 
Body is under constant threat to develop acidosis, because of production of lot of 
acids during metabolic activities. However, it is prevented by kidneys, lungs and 
blood buffers, which eliminate these acids. Among these organs, kidneys play major 
role in preventing acidosis. In fact, kidneys are the only organs, which are capable of 
eliminating certain metabolic acids like sulfuric and phosphoric acids. 
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    2.  HEMOPOIETIC FUNCTION 
Kidneys stimulate the production of erythrocytes by secreting erythropoietin. 
Erythropoietin is the important stimulating factor for erythropoiesis. Kidney also 
secretes another factor called thrombopoietin, which stimulates the production of 
thrombocytes. 
     3.ENDOCRINE FUNCTION 
Kidneys secrete many hormonal substances in addition to erythropoietin and     
thrombopoietin. The hormones secreted by kidneys are: 
a. Erythropoietin 
b. Thrombopoietin 
c. Renin 
d. 1, 25 – Dihydroxycholecalciferol 
e. Prostaglandins 
 
4.REGULATION OF BLOOD PRESSURE 
       Kidneys play an important role in the regulation of arterial blood pressure. 
Kidneys regulate arterial blood pressure by two ways: 
1. By regulating the volume of extracellular fluid 
2. Through renin – angiotensin mechanism 
 
5.REGULATION OF BLOOD CALCIUM LEVEL 
Kidneys play a role in the regulation of blood calcium level by activating 1, 25 – 
dihydroxycholecalciferol into vitamin D. Vitamin D is necessary for the absorption of 
calcium from intestine.
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 MECHANISM OF URINE FORMATION 
 
 
                                         
 
 The process involve in urine formation are, 
1. Glomerular filtration 
2. Tubular reabsorption 
3. Tubular secretion 
 
GLOMERULAR FILTRATION 
 Glomerular filtrate is protein free plasma. Glomerular filtration is depends upon 
hydrostatic pressure of the afferent arterioles, glomerular capillary pressure and colloidal 
osmotic pressure. The glomerular filter contains all the substance present in the plasma 
except colloids. 
 Normal amount of urine excreted per day is about 1.5 litres. The glomerular 
filtrate is alkaline. It contains water, small quantities of urea, glucose, potassium, 
calcium, bicarbonates and uric acid. 
 
TUBULAR REABSORPTION 
 When the glomerular filtrate flows through the tubular portion of nephron, both 
quantitive and qualitative changes occur. Large quantity of water (more than 99%), 
electrolytes and other substances are reabsorbed by the tubular epithelial cells. The 
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reabsorbed substances move into the interstitial fluid of renal medulla. And, from here, 
the substances move into the blood in peritubular capillaries. 
 Since the substances are taken back into the blood from the glomerular filtrate, the 
entire process is called tubular reabsorption. 
 
  TUBULAR SECRETION 
 In addition to reabsorption from renal tubules, some substances are also secreted 
into the lumen from the peritubular capillaries through the tubular epithelial cells. It is 
known as tubular secretion or tubular excretion. 
  Thus, urine is formed in the nephron by the processes of glomerular filtration, 
selective reabsorption and tubular secretion.
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                                                        URETERS 
The ureters are a pair of narrow, thick-walled muscular tubes which convey urine 
from the kidneys to the urinary bladder.  
They lie deep to the peritoneum, closely applied to the posterior abdominal wall in 
the upper part, and to the lateral pelvic wall in the lower part. 
 
DIMENSIONS 
Each ureter is about 25 cm (10 in.) long, of which the upper half (5 in.) lies in the 
abdomen, and the lower half (5 in.) in the pelvis. It measures about 3mm in diameter, but 
it is slightly constricted at three places. 
 
COURSE 
The ureter begins within the renal sinus as a funnel shaped dilatation, called the renal 
pelvis. The pelvis issues from the hilus of the kidney, descends along its median margin, 
or partly behind it. Gradually it narrows till at the lower end of the kidney it becomes the 
ureter proper. 
The ureter passes downwards and slightly medially on the psoas major muscle, and 
enters the pelvis by crossing in front of the termination of the common iliac artery. In the 
lesser or true pelvis the ureter at first runs downwards, and slightly backwards and 
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laterally, following the anterior margin of the greater sciatic notch. Opposite the ischial 
spine it turns forwards and medially to reach the base of the urinary bladder. The ureter 
enters the bladder wall obliquely to open into it at the lateral angle of its trigone. 
 
  CONSTRICTIONS 
The ureter is slightly constricted at three places: 1) at the pelviureteric junction; 2) 
at the brim of the lesser pelvis; 3) at its passage through the bladder wall. The renal 
stones tend to get arrested at these places. 
 
BLOOD SUPPLY 
Upper part receives branches from renal artery, gonadal or colic vessels, middle 
part receives branches from aorta, the gonadal or iliac vessels, and pelvic part is supplied 
by branches from the vesical, middle rectal or uterine vessels. 
 
NERVE SUPPLY 
The ureter is supplied by sympathetic from T10 – L1 segments and parasympathetic 
from S2 – S4 nerves. They reach the ureter though the renal, aortic and hypogastric 
plexuses. All the nerves appear to be sensory in function.
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                                                URINARY BLADDER 
 
The urinary bladder is a muscular reservoir of urine, which lies in the anterior part 
of the pelvic cavity. The detrusor muscle of urinary bladder is arranged in whorls and 
spirals and is adapted for mass contraction rather than peristalsis. 
 
SIZE, SHAPE AND POSITION 
The bladder varies in its size, shape and position according to the amount of urine 
it contains. When empty it lies entirely within the pelvis; but as it fills it expands and 
extends upwards into the abdominal cavity, reaching up to the umbilicus or even higher. 
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EXTERNAL FEATURES 
An empty bladder is tetrahedral in shape and has: a) An apex, directed forwards; b) a 
base or fundus, directed backwards; c) a neck, which is the lowest and most fixed part of 
the bladder; d) three surfaces, superior and right and left inferolateral; and e) four 
borders, two lateral, one anterior and one posterior. 
A full bladder is ovoid in shape and has: a) An apex, directed upwards towards the 
umbilicus; b) a neck, directed downwards, and c) two surfaces, anterior and posterior. 
 
INTERNAL SPHINCTER OF THE BLADDER 
The bladder wall is made up of longitudinal and circular layers of smooth muscles 
and they are called detrusor muscle. In the trigone in addition to detrusor muscle, there is 
trigonal muscle of bell. There is no definite circular muscle fibre at the neck of the 
bladder stop at the level of neck. Longitudinal fibres from the posterior wall diverge to 
pass around the urethra on both sides. 
 
CAPACITY OF THE BLADDER 
The mean capacity of the bladder in an adult male is 220 ml, varying from 120 to 
320 ml. filling beyond 220 ml causes a desire to micturate, and the bladder is usually 
emptied when filled to about 250 – 300 ml. filling upto 500 ml may be tolerated, but 
beyond this it becomes painful. Referred pain is felt in the lower part of the anterior 
abdominal wall, perineum and penis (T11 to L2; S2 – S4). 
 
BLOOD SUPPLY 
Superior vesicle arteries and inferior vesicle arteries supplies the bladder. In 
addition branches from obturator and inferior gluteal artery are supplied to the bladder. 
 
NERVE SUPPLY 
Sympathetic fibers arise from T11 – L2 segment. Parasympathetic fibres branches 
from S2 – S4. Somatic pudental nerve supplies the sphincter urethrae which is 
voluntary.
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                                                            URETHRA 
 
Urethra is a tubular passage extending from the neck of the bladder to the external 
urethral orifice. 
 The male urethra extends from the internal urethral orifice at the neck of urinary 
bladder to the external urethral orifice at the tip of the penis. It is about 20 cm long in 
flaccid state of the penis; the long axis of urethra shows 2 curvatures and is therefore 
S shaped. In the erect state it becomes J shaped. 
It is divided into 3 parts 
1) Prostatic part                     : Passes through prostate (3 cm long) 
2) Membraneous part            : Surrounded by sphincter (2 cm long) 
3) Spongy part (Penile part)  : Passes through the bulb and carpus 
                                             spongiosum (15 cm long) 
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SPHINCTER OF THE URETHRA 
 There are 2 sphincters, in relation with urethra internal and external. The internal 
sphincter made up of smooth muscle fibre and situated at the neck of the bladder is 
supplied by sympathetic nerves from lower thoracic segments and upper lumbar 
segments. 
 The external sphincter made of light striated muscle fibre surrounds the 
membraneous part of urethra; it is supplied by prineal branch of the pudental nerve (S2 to 
S4). 
 
BLOOD SUPPLY 
 Branches of internal pudental artery supplies urethra. 
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THE FEMALE URETHRA 
The female urethra is only 4 cm long and 6 mm in diameter. Developmentally, it 
corresponds to the upper part of the prostatic urethra of the male. 
 It begins at the internal urethral orifices roughly 5 cm behind the middle of the 
pubic symphysis. It runs downwards and forwards embedded in the anterior wall of the 
vagina, traverse the urogenital diaphragm and ends at the lateral urethral orifices in the 
vestibule. 
 The mucosa of the urethra is much folded and contains numerous mucous glands 
and lacunae which open into the urethra. The collections of mucous glands one on each 
side of the upper part of the urethra is called the paraurethral glands of skene. 
 The female urethra is dilatable.
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                               RENAL CALCULI (UROLITHIASIS) 
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It refers to calculus formation at any level in the urinary tract but most arise in the 
kidney.calculi are common in the renal pelvis, calyces and collecting ducts of people in 
industrialized countries, and is the third most common disorder of the urinary tract. 
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    Urolithiasis is a frequent clinical problem, affecting 5 to 10% of Americans in 
theirlifetime. Males are affected more often than females and the peak age at onset is 
between20 and 30 years. Familial hereditary predisposition to stone formation has long 
been known. Many of the inborn errors of metabolism, such as gout   cystinuria, and 
primaryhyperoxaluria, provide good examples of hereditary disease characterized 
byexcessiveproduction and excretion of stone -forming substances.
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    In underdeveloped countries nephrolithiasis is rare. In Britain and USA the incidence 
of renal calculi has become at least 10 times higher in the past 90 years. This increase 
may be related to changes in diet e.g. increase in protein diet. Current annual incidence in 
Britain and the USA ranges from 6.87 to 20.8 per 10,000 of the population. A familial 
tendency toward stone formation has long been recognized 
 If stones grow to sufficient size (usually at least 3 millimeters (0.12 in)) they can 
cause obstruction of the ureter. Ureteral obstruction causes postrenal azotemia and 
hydronephrosis (distention and dilation of the renal pelvis and calyces), as well as spasm 
of the ureter. This leads to pain, most commonly felt in the flank (the area between the 
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ribs and hip), lower abdomen, and groin (a condition called renal colic). Renal colic can 
be associated with nausea, vomiting, fever, blood in the urine, pus in the urine, and 
painful urination. Renal colic typically comes in waves lasting 20 to 60 minutes, 
beginning in the flank or lower back and often radiating to the groin or genitals. The 
diagnosis of kidney stones is made on the basis of information obtained from the history, 
physical examination, urinalysis and radiographic studies. Ultrasound examination and 
blood tests may also aid in the diagnosis.
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Renal calculi are formed when the urine is supersaturated with salt and minerals 
such as calcium oxalate, struvite (ammonium magnesium phosphate), uric acid and 
cystine.60-80% of stones contain calcium
57
. They vary considerably in size from small 
'gravel-like' stones, to large staghorn calculi. The calculi may stay in the position in 
which they are formed, or migrate down the urinary tract, producing symptoms along the 
way. Studies suggest that the initial factor involved in the formation of a stone may be the 
presence of nanobacteria that form a calcium phosphate shell
58,59.
. 
The other factor that leads to stone production is the formation of Randall's 
plaques. Calcium oxalate precipitates form in the basement membrane of the thin loops of 
Henle; these eventually accumulate in the subepithelial space of the renal papillae, 
leading to a Randall's plaque and eventually a calculus.
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Pathophysiology 
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       Urinary calculi are consist of aggregates of crystals, usually containing calcium or 
phosphate in combination with small amounts of proteins and glycoproteins. In 
developed countries, however, most calculi occur in healthy young men, in whom 
investigations reveal no clear predisposing cause. Renal stones vary greatly in size. There 
may be particles like sand anywhere in the urinary tract, or large round stones in the 
bladder.  
 
   In developing countries bladder stones are common, particularly  in  children. In 
developed countries, the incidence of childhood bladder stones is low; renal stones in 
adults are more common. Staghorn calculi fill the whole renal pelvis and branch into the 
calyces; they are usually associated with infection and composed largely of struvite.  
 
     Deposits of calcium may be present throughout the renal parenchyma, giving rise to 
fine calcification within it (nephrocalcinosis), especially in patients with renal tubular 
acidosis, hyperparathyroidism, vitamin D intoxication and healed renal tuberculosis. 
Cortical nephro calcinosis  may occur in areas of cortical necrosis, typically after AKI in 
pregnancy or other severe AKI. 
PREVALENCE 
    Renal stone disease is common , affecting individuals of all countries and ethnic 
groups. In the UK, the prevalence is about 1.2%, with a lifetime risk of developing a 
renal stone at age 60-70% of about 7% in men. In some regions the risk is higher, most 
notably in countries like Saudi Arabia, where the lifetime risk of developing a renal stone 
in men aged 60-70 is just over 20%
61
.  
EPIDEMIOLOGY 
 Renal stones are common, being present at some time in one in ten of the 
population, although a significant proportion will remain asymptomatic. 
 The annual incidence is about 1-2 cases of acute renal colic per 1,000 people and 
the average lifetime risk around 5-10%. 
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 Men are more commonly affected than women, with a male to female ratio of 3:1. 
The difference between the sexes is gradually being eroded. This is thought to be 
due to lifestyle-associated factors, such as obesity and a Western diet. 
 The peak age for developing stones is between 30 and 50 and recurrence is 
common
57
. 
ETIOLOGY AND PATHOGENESIS 
  The crystals in the stone in the kidney are commonly mixed, although there is usually a 
preponderance of crystals from one particular solute. 70-75% of renal stones are 
composed almost entirely of calcium oxalate, mixed with calcium phosphate. 15% of 
calculi consist predominantly of magnesium ammonium phosphate (struvite). Uric acid 
stones and cysteine stones together account for about 10% of calculi. Very rarely stones 
are made up of almost pure xanthine, silica or some chemical foreign to the body. 
Uric acid crystals are commoner in some parts of the Middle East, India and North Africa 
than in Europe and the USA. 
The formation of stones within the kidney is not a specific disease, it is potential 
complication of many different disorders. The cause is obscure. The most important is 
almost certainly an increased urine concentration of the some constiuents
62
. 
TYPES OF RENAL CALCULI 
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  There are  4 main tyoes of renal calculi- calcium containing, mixed(struvite), uric acid 
and cysteine stones, a few rare types. 
1) CALCIUM STONES 
                                   
 
        Calcium stones are the most common comprising about 75% of all urinary calculi. 
They may be pure stones of calcium oxalate (50%), or calcium phosphate (5%), or 
mixture of calcium oxalate and calcium phosphate (45%). 
Etiology 
    Etiology  of calcium stones are variable. 
About 50% of patients with calcium stones have idiopathic hypercalciuria without 
hypercalcaemia.  
Approximately 10 % cases are associated with hypercalcaemia and hypercalciuria, the 
most commonly due to hyperparathyroidism, or a defect in the bowel (i.e. absorptive 
hypercalciuria), or in the kidney (i.e. renal hypercalciuria). 
About 15% of patients with calcium stones have hyperuricosuria with a normal blood 
uric acid level and without any abnormality of calcium metabolism. 
In about 25% of patients with clcium stones, the cause is known as there is no 
abnormality in urinary excretion of calcium, uric acid or oxalate and is referred to as 
idiopathic calcium stone disease. 
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 Pathogenesis  
    The mechanism of calcium stone formation is explained on the basis of imbalance 
between the degree of supersaturation of the ions forming the stone and the concentration 
of inhibitors in the urine. Most likely site where the crystals of calcium oxalate and / or 
calcium phosphate are precipitated is the tubular lining or around some fragment of 
debris  in the tubule acting as nidus of the stone. The predisposing factors contributing to 
formation of calcium stones are alkaline pH, decreased urinary volume and increased 
excretion of oxalate and uric acid 
Morphology  
     Calcium stones are usually small (less than a centimeter), ovaid, hard, with granular 
rough surface. They are dark brown due to old blood pigment deposited in them as a 
result of repeated trauma caused to the urinary tract by these sharp – edged stones. 
2.MIXED STONES 
                        
About 15% of urinary calculi are made of magnesium-ammonium-calcium phosphate, 
often called struvite; hence mixed stones are also called as struvite stones or triple 
phosphate stones. 
Etiology  
Struvite stones are formed as a result of infection of the urinary tract with urea- splitting 
organisms that produce urease such as by specious of Proteus, and occasionally 
klebsiella, pseudomonas, and  Enterobacter. these are, therefore, also known as infection 
– induced stones. However, E.coli does not form urease. 
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Morphology  
     Struvite stones are yellow- white or grey. They tend to be soft and irregular in shape. 
Staghorn stone which is large, solitary stone that takes the shape of the renal pelvis where 
it is often formed is an example of struvite stone
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3).URIC ACID STONES  
                           
Approximately 6% of urinary calculi are made of uric acid. Uric acid calculi are 
radiolucent unlike radio- opaque calcium stones. 
Etiology  
Uric acid stones are frequently formed in cases with hyperuricaemia and hyperuricosuria 
such as due to primary gout or secondary gout due to myeloproliferative disorders        
(e.g. in  leukaemias), especially those on chemotherapy, and administration of uricosuric 
drugs (e.g. salicylates, probenacid). Other factors contributing to their formation are 
acidic urinary pH (below 6) and low urine volume. 
Pathogenesis 
    The solubility of uric acid at pH of 7 is 200 mg/ dl while at pH of 5 is 15 mg /dl. Thus 
as the urine becomes more acidic, the solubility of uric acid in urine decreases and 
precipitation of uric acid crystals increases favoring the formation of uric acid stones. 
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Hyperuricosuria is the most important factor in the production of uric acid stones, while 
hyperuricaemia is found in about half the cases. 
Morphology  
Uric acid stones are smooth, yellowish- brown, hard and often multiple. On cut section, 
they show laminated structure. 
 
4).CYSTINE STONES  
   
                              
 
Cysteine stones comprise less than 2% of urinary calculi. 
 
 Etiology  
Cysteine are associated with cystinuria due to a genitically- determined defect in the 
transport of cysteine and other amino acids across the cell membrane of the renal tubules 
and the small intestinal mucosa. 
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Pathogenesis  
The resultant excessive excretion of cysteine which is least soluble of the naturally- 
occurring amino acids leads to formation of crystals and eventually cysteine calculi. 
Morphology  
cysteine  stones are small, rounded, smooth and multiple. They are yellowish and waxy. 
5.OTHER CALCULI 
Less than 2% of urinary calculi consist of other rare types such as due to inherited 
abnormality of enzyme metabolism e.g. hereditary xanthinuria developing xanthine 
stones
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  CLINICAL COURSE 
    Stones are of importance when they obstruct urinary flow or produce ulceration and 
bleeding. They may be present without producing any symptoms or significant renal 
damage. In general, smaller stones are most hazardous, as they may pass into the ureters, 
producing pain referred to as colic (one of the most intense forms of pain) as well as 
ureteral obstruction. Larger stones cannot enter the ureters and are more likely to remain 
silent within the renal pelvis. Commonly, these larger stones first manifest themselves by 
hematuria. Stones also predispose to superimposed infection, both by their obstructive 
nature and by the trauma they produce
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.  
MORPHOLOGY OF KIDNEY 
    In 80% of patients, stones are unilateral. Common sites are renal pelvis, calyces and 
the bladder. Calcium oxalate crystals are mostly unilateral and solitary. They are usually 
either yellow-brown or dark from altered blood, and hard. Predominantly oxalate calculi 
may be nodular with smaller blunt spikes; mixed oxalate and phosphate stones may be 
fairly smooth. If small they are triangular in section. The nodular form may be called 
mulberry type in Britain or the jackstone type in the USA. Occasionally progressive 
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accretion of salts leads to the development of branching structures known as staghorn  
calculi, which create a cast of the renal pelvic and calyceal system. These massive stones 
are usually composed of magnesium ammonium phosphates
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.  
CLINICAL FEATURES    
 The clinical presentation is highly variable. Most patients with renal stone disease are 
asymptomatic, whereas others present with pain, hematuria, UTI, or urinary tract 
infection.  
   A common presentation is with acute loin pain radiating to the anterior abdominal wall, 
together with hematuria; a symptom complex termed renal or ureteric calculi. This most 
commonly caused by a calculus but the same symptoms can occur in association with a 
sloughed renal papilla, tumour or blood clot. 
    The patient is suddenly aware of pain in the loin, which radiates round the flank to the 
groin and often into the testis or labium, in the sensory distribution of the first lumbar 
nerve. The pain steadily increase in intensity to reach a peak in a few minutes.  
  The patient is restless and generally tries unsuccessfully to obtain relief by changing 
position or packing the room. There is pallor, sweating, and often vomiting. Frequency, 
dysuria, and hematuria may occur. The intense pain usually subsides within 2 hours but 
may continue unabated for hours or days
61
.  
PRESENTATION   
 Many stones are asymptomatic and discovered during investigations for other 
conditions. 
 The classical features of renal colic (or ureteric colic) are sudden severe pain. It is 
usually caused by stones in the kidney, renal pelvis or ureter, causing dilatation, 
stretching and spasm of the ureter. In most cases no cause is found: 
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 Pain starts in the loin about the level of the costovertebral angle (but sometimes 
lower) and moves to the groin, with tenderness of the loin or renal angle, 
sometimes with haematuria. 
 If the stone is high and distends the renal capsule then pain will be in the flank but 
as it moves down pain will move anteriorly and down towards the groin. 
 A stone that is moving is often more painful than a stone that is static. 
 The pain radiates down to the testis, scrotum, labia or anterior thigh. 
 Whereas the pain of biliary or intestinal colic is intermittent, the pain of renal 
colic is more constant but there are often periods of relief or just a dull ache 
before it returns. The pain may change as the stone moves. The patient is often 
able to point to the place of maximal pain and this has a good correlation with the 
current site of the stone. 
       Other symptoms which may be present include:  
 Rigors and fever. 
 Dysuria. 
 Haematuria. 
 Urinary retention. 
 Nausea and vomiting
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PREDISPOSING FACTORS FOR KIDNEY STONES 
Environmental and dietary: 
 Low urine volumes, high ambient temperatures, low fluid intake 
 Diet: high protein intake, high sodium, low calcium 
 High sodium excretion 
 High urate excretion 
 High oxalate excretion 
 Low citrate excretion 
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Acquired causes: 
 Hypercalcemia of any cause 
 Ileal disease or resection (leads to increased oxalate absorption and urinary 
excretion) 
 Renal tubular acidosis type I 
Congenital and inherited causes: 
 Familial hypercalciuria 
 Renal tubular acidosis type I (distal) 
 Medullary sponge kidney 
 Cystinuria 
 Primary hyperoxaluria 
The majority of stones pass spontaneously within 48 hours. However, some 
stones may not. There are several factors which influence the ability to pass a stone. 
These include the size of the person, prior stone passage, prostate enlargement, 
pregnancy, and the size of the stone. A 4 mm stone has an 80% chance of passage while a 
5 mm stone has a 20% chance. If a stone does not pass, certain procedures (usually by a 
urology specialist doctor) may be needed
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RISK FACTORS 
Several risk factors are recognised to increase the potential of a susceptible individual to 
develop stones. These include: 
 Anatomical anomalies in the kidneys and/or urinary tract - eg, horseshoe 
kidney, ureteral stricture. 
 Family history of renal stones. 
 Hypertension. 
 Gout. 
 Hyperparathyroidism. 
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 Immobilisation. 
 Relative dehydration. 
 Metabolic disorders which increase excretion of solutes - eg, chronic 
metabolic acidosis, hypercalciuria, hyperuricosuria. 
 Deficiency of citrate in the urine. 
 Cystinuria (an autosomal-recessive aminoaciduria). 
 Drugs - eg, diuretics such as triamterene and calcium/vitamin D supplements. 
 More common occurrence in hot climates. 
 Increased risk of stones in higher socio-economic groups. 
 Contamination - as demonstrated by a spate of melamine-contaminated infant 
milk formula
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EXAMINATION 
 The patient with colic of any sort writhes around in agony. This is in contrast to 
the patient with peritoneal irritation who lies still. 
 The patient is apyrexial in uncomplicated renal colic (pyrexia suggests infection 
and the body temperature is usually very high with pyelonephritis). 
 Examination of the abdomen can sometimes reveal tenderness over the affected 
loin. Bowel sounds may be reduced. This is common with any severe pain. 
 There may be severe pain in the testis but the testis should not be tender. 
 Blood pressure may be low. 
 Full and thorough abdominal examination is essential to check for other possible 
diagnoses - eg, acute appendicitis, ectopic pregnancy, aortic aneurysm
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sDIFFERENTIAL DIAGNOSIS  
   This depends upon the position of the pain and the presence or absence of pyrexia and 
includes: 
 Biliary colic. 
 Pyelonephritis: very high temperature. Pain is unlikely to radiate to the groin. 
 Acute pancreatitis 
62 
 
 Acute appendicitis 
 Perforated peptic ulcer. 
 Epididymo – orchitis or torsion of the testis: very tender testis. 
 Sinister causes of back pain: usually tender over vertebrae. 
 Dissection of an aortic aneurysm: the patient who presents with features of renal 
colic for the first time over the age of 60. This may be dissection of aortic 
aneurysm leading to ruptured aortic aneurysm.  
 Drug addiction: there are reports of people with fictitious stories of renal colic, 
designed to obtain an injection of pethidine. These patients tend to be abusive 
when offered anything other than pethidine
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INVESTIGATIONS 
Basic analysis should include: 
 Blood for FBC, CRP, renal function, electrolytes, calcium, phosphate and urate, 
creatinine. 
 Midstream specimen of urine for microscopy (pyuria suggests infection), culture 
and sensitivities. 
 Prothrombin time and international normalised ratio if intervention is planned. 
 Stick testing of urine for red cells (suggestive of urolithiasis), white cells and 
nitrites (both suggestive of infection) and pH (pH above 7 suggests urea-splitting 
organisms such as Proteus spp. whilst a pH below 5 suggests uric acid stones). 
  Intravenous pyelogram (IVP)
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 . 
 Computed tomography (CT) 
  Ultrasound scanning may be helpful to differentiate radio-opaque from 
radiolucent stones and in detecting evidence of obstruction. 
 Plain X-rays of the kidney, ureter and bladder (KUB) are useful in watching the 
passage of radio-opaque stones (around 75% of stones are of calcium and so will 
be radio-opaque). 
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 The European Association of Urology's guidelines on urolithiasis recommend 
stone analysis for: 
 All first-time stone formers. 
 All patients with recurrent stones who are on pharmacological preventing therapy. 
 Patients who have had early recurrence after complete stone clearance. 
 Late recurrence after a long stone-free period (stone composition may change)
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. 
COMPLICATIONS  
  The complications of calcium oxalate and hydroxyapatite renal calculi are acute and 
chronic pyelonephritis, hydronephrosis and obstructive nephropathy.  
  The stone fragments may obstruct the ureter. This occurs in 5-15% of cases. 8% of 
patients develop hypertension or exacerbation of pre- existing hypertension within 1 year. 
thirdly there is a risk of renal damage.  
  HYDRONEPHROSIS 
   In bilateral complete obstruction, patient present with anuria.  When the obstruction is 
below the bladder the dominant symptoms are bladder distention. Unilateral 
hydronephrosis may remain completely silent for long periods of time. Enlargement of 
kidney is made out on physical examination. Sometimes the obstructing cause e.g. calculi 
can produce symptoms. 
Early removal of the cause of obstruction can return the full function of the kidney. In 
long standing cases the changes become irreversible. 
Two metabolic disorders need to be mentioned here which are associated with 
precipitation of the crystalline material causing obstruction to urine flow. 
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1.HYPERURICAEMIA 
 Uric acid stones are formed In 22% of patients with gout. The urate crystals get 
deposited in distal collecting tubules.  Collecting ducts as well in the interstitium, forming 
gouty tophus. Uric acid  crystal deposition takes place also following chemotherapy to the 
patients of leukemia and lymphoma. this is due to the breaking down of nucleic acid.  
2.HYPERCALCAEMIA 
 Hyperparathyroidism, end stage kidney disease, vit. D intoxication, excessive calcium 
intake, osteolytic disease of bones, milk- alkali syndrome are some of the conditions 
giving rise to hypercalcaemia. This induces deposition of calcium in renal tubules called 
nephrocalcinosis.  Sometimes, the deposition can also form renal stones
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. 
Complete blockage of the urinary flow from a kidney decreases glomerular filtration rate 
(GFR) and, if it persists for more than 48 hours, may cause irreversible renal damage. 
If ureteric stones cause symptoms after four weeks, there is a 20% risk of complications, 
including deterioration of renal function, sepsis and ureteric stricture. 
Infection can be life-threatening. 
Persisting obstruction predisposes to pyelonephritis
70
. 
PROGNOSIS 
  The prognosis will depend upon the underlying condition causing the renal stones. 
Calcium oxalate and hydroxyapatite stones per se rarely lead to renal failure. If at the 
time of diagnosis there is renal damage due to the calculi then this may cause renal 
dysfunction and hypertension. The main problem is recurrence unless the causative 
condition can be treated ; the recurrence rate is high, approaching 70% by 10 years after 
spontaneous passage or surgical removal of a calculus
71
. 
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 Most symptomatic renal stones are small (less than 5 mm in diameter) and pass 
spontaneously. 
 Stones less than 5 mm in diameter pass spontaneously in up to 80% of people. 
 Stones between 5 mm and 10 mm in diameter pass spontaneously in about 50% of 
people. 
 Stones larger than 1 cm in diameter usually require intervention (urgent intervention 
is required if complete obstruction or infection is present). 
 Two thirds of stones that pass spontaneously will do so within four weeks of onset of 
symptoms. 
 A stone that has not passed within 1-2 months is unlikely to pass spontaneously. 
 The following features predispose to recurrent stone formation: 
 First attack before 25 years of age. 
 Single functioning kidney. 
 A disease that predisposes to stone formation. 
 Abnormalities of the renal tract. 
PREVENTION 
Recurrence of renal stones is common and therefore patients who have had a renal 
stone should be advised to adapt and adopt several lifestyle measures which will help to 
prevent or delay recurrence: 
 Increase fluid intake to maintain urine output at 2-3 litres per day. 
 Reduce salt intake. 
 Reduce the amount of meat and animal protein eaten. 
 Reduce oxalate intake (foods rich in oxalate include chocolate, rhubarb, nuts) and 
urate-rich foods (eg, certain fish). 
 Drink regular cranberry juice: increases citrate excretion and reduces oxalate and 
phosphate excretion. 
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CALCIUM 
 Maintain good calcium intake(calcium forms an insoluble salt with dietary 
oxalate, lowering oxalate absorption and excretion). 
 Avoid calcium supplements separate from meals (increase calcium excretion 
without reducing oxalate excretion).  
OXALATE 
    Depending on the composition of the stone, medication to prevent further 
stoneformation is sometimes given - eg, thiazide diuretics (for calcium stones),allopurinol 
(for uric acid stones) and calcium citrate (for oxalate stones)
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ACTIONS OF TRIAL DRUGS 
 
 
 
STANDARD OPERATIVE PROCEDURE              
  Take 175gms of Potash nitras a clay pot, heat it over fire and the salt will melt. By this 
time add Betle leaf juice about 168ml, stir it un till the juice gets immerge with the salt. 
Pour this over a wooden plate or a clean Kalvam. 
Then transfer it into a pot and heat by adding Betel leaf juice till the juice immerge with 
the ingredient and become semi solid state. Repeat the same procedure for 3 times. 
Now the color will turn into red. Otherwise repeat this till the color changes in to red let it 
cool and dry then bottle it up. 
 
DURATION: 48 days(1mandalam)                                               
               DOSE: 130 mg to 260 mg bd. 
ADJUVANT: Mullangi kizhangu Chaaru
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S.No Drugs Botanical name Actions 
1        Potassium nitrate              , 
          , 
           .72 
2        Piper betle         , 
         , 
      ,      , 
        ,    
        ,      
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           .73 
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  MATERIALS AND METHODS 
 
                                            PROTOCOL 
 
 Study Design 
    An open pilot study on kalladaippu was carried out in the post graduate department of 
maruthuvam in Govt.Siddha Medical College attached to Arignar Anna Hospital of 
Indian Medicine, Chennai – 106 during the period of 2014 – 2016. 
   The study was approved by Instititional Ethics Committee (IEC) and the approval 
number is GSMC-CH-ME-3/001/2014. 
Sample size 
   The study is conducted in 40 selected kalladaippu patients of both genders between age 
groups of 18 to 60 years. 
 
Selection Criteria 
 The patients having following parameters are selected for the study. 
 Pain in the flank  
 Burning Micturition 
 Oliguria 
 Dysuria  
 Nausea  
 Vomiting  
 Haematuria  
 Fever  
 History of Urolithiasis (with USG-Whole Abdomen reports)  
Exclusion Criteria 
 Age group less than 18 
 Stag horn calculus 
 Pyonephrosis 
 Calculi associated with elevated serum creatinine level 
 Calculi in pregnancy 
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Proforma  
 The case sheet proforma for kalladaippu was prepared based on Siddha diagnostic 
methodology with necessary modern techniques. 
 
History taking 
 For better treatments and results a detailed clinical history was taken regarding  
present illness, past illness, family history, menstrual history, occupational history, socio 
economic status, residential area, etc., 
  
Investigation 
 All patients were screened by the following investigations. This was carried out 
regularly before and after treatment. 
 
 Blood for biochemical examination 
The blood was tested for sugar, urea, serum creatinine to know the renal 
function and its excretion. 
 
 Urine Examination 
         Albumin, Sugar, Deposits. 
 
 Ultra sonogram 
Ultra sonogram of complete abdomen including KUB was done in cases to 
know the location, size and number of calculi. 
 
Drug and dose schedule 
 Vediyuppu chendooram– 130 mg to 260 mg, bd after food with radish juice for 48 
days 
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RESULTS AND OBSERVATION 
    40 cases having kalladaippu were selected and treated in OPD of PG maruthuvam 
department attached to AAGHIM, Chennai – 106 during the year 2014 – 2016. The result 
and observation during that clinical study are as follows. 
 Gender distribution 
 Age distribution 
 Occupation 
 Socio- economic status 
 Dietary habits 
  Seasonal occurence 
 Distribution of thinai 
 Distribution of mukkutram – vatham 
 Distribution of mukkutram – pitham  
 Distribution of mukkutram – kabham 
 Ezhu udal thathukkal 
 En vagai thervugal 
 Naadi 
 Neikuri 
 Clinical features 
 Clinical prognosis 
 Distribution of calculi based on location 
 Grading of results 
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GENDER DISTRIBUTION 
S.No GENDER NUMBER OF CASES PERCENTAGE (%) 
1 Male 23 57.5% 
2 Female 17 42.5% 
 
INFERENCE 
 About 57.5% were males and 42.5% were females 
 Literature: according to literature males are more prone to renal calculi 
 
 
Male 
57.5% 
female 
42.5% 
PERCENTAGE (%) 
78 
 
 
AGE DISTRIBUTION 
S.No AGE IN YEARS NUMBER OF 
CASES 
PERCENTAGE (%) 
1 18 – 20 yrs 1 2.5% 
2 21 - 30 yrs 7 17.5% 
3 31 - 40 yrs 14 35% 
4 41 - 50 yrs 12 30% 
5 51 - 60 yrs 6 15% 
 
 
INFERENCE 
 Majority of the case that is 35% were in the 3rd decade, 30% were in the 4th 
decade, 17.5% were in the 2
nd
 decade, 15% were in the 5
th
 decade, 2.5%were in 1
st
 
decade. 
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                                                OCCUPATION 
S.No OCCUPATION NUMBER OF 
CASES 
PERCENTAGE (%) 
1 Office worker 16 40% 
2 House Wife 8 20% 
3 Business 4 10% 
4 Electrician 1 2.5% 
5 Student 2 5% 
6 Farmer 9 22.5% 
 
 
 
INFERENCE 
 0ut of 40 patients (100%), 40% were office worker, 20% were house wife,  10% 
were business, 2.5% were electrician, 5% were student, 22.5% were farmer. 
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SOCIO – ECONOMIC STATUS 
S.No SOCIO – ECONOMIC 
STATUS 
NUMBER OF 
CASES 
PERCENTAGE 
(%) 
1 Low Income  
( below 25,000 per annum) 
20 50% 
2 Moderate Income  
(25,000 – 50,000 per annum) 
15 37.5% 
3 High Income  
( Above 50,000 per annum) 
5 12.5% 
 
 
 
 
INFERENCE: 
 Among 40 cases 50% comes under low economic status, 37.5% of them under 
moderate status and 12.5% of them under high income status. 
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                                       DIETARY HABITS 
S.No DIET NUMBER OF 
CASES 
PERCENTAGE 
(%) 
1 Vegetarian 10 25% 
2 Mixed diet 30 75% 
 
 
 
INFERENCE 
 Among 40 patients, 10 patients (25%) were taking vegetarian food and 30 patients 
(75%) were taking mixed diet. 
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SEASONAL OCCURENCE 
S.No KAALAM (Season) NUMBER OF CASES PERCENTAGE (%) 
1 Kaar kaalam 
(    ,        ) 
1 2.5% 
2 koothir Kaalam 
(ஐ    ,        ) 
1 2.5% 
3 Munpani kaalam 
(      ,   ) 
7 17.5% 
4 Pinpani kaalam 
(    ,      ) 
21 52.5% 
5 Elavenir kaalam 
(     ,       ) 
5 12.5% 
6 Muthuvenir kaalam 
(   ,   ) 
5 12.5% 
 
 
INFERENCE 
 According to paruvakaalam highest incident of 21 cases (52.5%) were noted in 
pinpani kaalam , 7 cases (17.5%) were noted in munpani kaalam, 5 cases (12.5%) were 
noted in elavenir kaalam, 5 cases (12.5%) were noted in muthuvenir kaalam, 1 case 
(2.5%) were noted in karkaalam And 1 case(2.5%) were noted in koothir kaalam. 
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DISTRIBUTION OF THINAI 
S.No THINAI NUMBER OF CASES PERCENTAGE (%) 
1 Kurinji 5 12.5% 
2 Mullai 1 2.5% 
3 Marutham 6 15% 
4 Neithal 28 70% 
5 Paalai 0 0% 
 
 
 
 
INFERENCE 
 According to thinai the highest distribution 70% was noted in neithal, 15% in 
marutham, 12.5% in kurinji, 2.5% in mullai. 
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        DISTRIBUTION OF MUKKUTRAM – VATHAM 
S.No VATHAM NUMBER OF CASES PERCENTAGE (%) 
1 Pranan 0 0% 
2 Abanan 40 100% 
3 Viyanan 40 100% 
4 Uthanan 4 10% 
5 Samanan 40 100% 
6 Nagan 0 0% 
7 Koorman 4 10% 
8 Kirukaran 8 20% 
9 Devathathan 12 30% 
10 Thananjeyan 0 0% 
 
 
INFERENCE 
Out of 40 patients Abanan was affected in 40 patients (100%), Viyanan was 
affected in 40 pateints (100%), Uthanan was affected in 4 patients (10%), Samanan was 
affected in 40 patients (100%), Koorman was affected in 4 patients (10%) and Kirukaran 
was affected in 8 patients (20%),Devathathan was affected in 12 patients(30%).  
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DISTRIBUTION OF MUKKUTRAM – PITHAM 
S.No PITHAM NUMBER OF CASES PERCENTAGE (%) 
1 Analagam 5 12.5% 
2 Ranjagam 10 22.5% 
3 Saathagam 40 100% 
4 Alosagam 4 10% 
5 Pirasagam 0 0% 
 
 
 
 
 
INFERENCE 
 Out of 40 patients Analagam was affected in 5 patients (12.5%), Ranjagam was 
affected in 10 patients (22.5%), Sathagam was affected in 40 patients (100%), Aalosagam 
was affected in 4 patients (10%). 
PERCENTAGE (%)
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 DISTRIBUTION OF MUKKUTRAM – KABHAM 
 
S.No KABHAM NUMBER OF 
CASES 
PERCENTAGE 
(%) 
1 Avalambagam 1 2.5% 
2 Klethagam 5 12.5% 
3 Pothagam 4 10% 
4 Tharpagam 4 10% 
5 Santhigam 18 45% 
 
 
 
 
 
INFERENCE 
 
Out of 40 patients, Avalambagam was affected in one patient(2.5%), Kiledhagam 
was affected in 5 patients (12.5%), Pothagam was affected in 4patients(10%), Tharpagam 
was affected in 4 patients(10%), Santhigam was affected in18 patients (45%). 
 
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
35.00%
40.00%
45.00%
2.50% 
12.50% 
10% 10% 
45% 
87 
 
EZHU UDAL THATHUKAL 
 
S.No EZHU UDAL 
THATHUKAL 
NUMBER OF 
CASES 
PERCENTAGE (%) 
1 Saaram 40 100% 
2 Senneer 10 25% 
3 Oon 2 5% 
4 Kozhupu 0 0% 
5 Enbu 13 32.5% 
6 Moolai 0 0% 
7 Sukkilam /Suronitham 0 0% 
 
 
 
 
 
INFERENCE 
 
 Out of 40 patients, Saaram was affected in 40 patients (100%), Senneer was 
affected in 10 patients (25%), Oon was affected in 2 patients(5%), Enbu was affected in 
13 patients (32..5%). 
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EN VAGAI THERVUGAL 
 
S.No EN VAGAI 
THERVUGAL 
NUMBER OF CASES PERCENTAGE (%) 
1 Naa 2 5% 
2 Niram 0 0% 
3 Mozhi 10 25% 
4 Vizhi 4 10% 
5 Sparisam 0 0% 
6 Malam 5 12.5% 
7 Moothiram 26 65% 
 
 
 
 
 
 
 INFERENCE 
 
In Envagai thervu,Naa was affected in 2 patients(5%), Mozhi was affected in 10 
patients(25%), Vizhi was affected in 4 patients (10%), Malam was affected in 5 patient 
(12.5%) and Moothiram was affected in 26 patients (65%). 
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  NAADI 
 
S.No NAADI NUMBER OF CASES PERCENTAGE (%) 
1 Vali Azhal 12 30% 
2 Vali Iyam 2 5% 
3 Azhal Vali 21 52.5% 
4 Kabha Vatham 2 5% 
5 Kabha Pitham 3 7.5% 
 
 
 
 
 
 
 
 INFERENCE 
 
 12 patients (30%) had Vali azhal naadi, 3 patients (5%) had  vali Iyam  naadi, 21 
patients (52.5%) had Azhal vali  naadi,2 patients (5%) had kabha vatham, and 3 patients 
(7.5%) had Kabha pitha naadi. 
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                                              NEIKURI 
 
S.No THATHU NEIKURI NUMBER OF 
CASES 
PERCENTAGE 
(%) 
1 Vatha neer Spread like snake 22 55% 
2 Pitha neer Spread like ring 12 30% 
3 Kabha neer Spread like pearl 6 15% 
 
 
 
 
INFERENCE 
 
 22 patients (55%) had vatha neer, 12 patients (30%) had Pitha neer, and 6 patients 
(15%) had Kabha neer. 
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                                         CLINICAL FEATURES 
 
S.No SIGNS & SYMPTOMS NUMBER OF CASES PERCENTAGE (%) 
1 Flank pain 40 100% 
2 Nausea 3 7.5% 
3 Vomiting 1 2.5% 
4 Burning Micturition 20 50% 
5 Dysuria 8 20% 
6 Oliguria 2 5% 
7 Fever 0 0%                                 
8 Retention 1 2.5% 
9               Hematuria 3 7.5% 
 
 
               
 
 
   INFERENCE 
 
 Out of 40 patients, 40 patients (100%) had Flank pain, 3 patients (7.5%) had 
Nausea, 1 patient (2.5%) had vomiting,20 patients (50%) had Burning Micturition, 
8patients (20%) had Dysuria, 2 patients (5%) had oliguria, 1 patient(2.5%) had urine 
retion,  and 3 patients (7.5%) had Hematuria 
100% 
7.50% 
2.50% 
50% 
20% 
5% 
0% 2.50% 
7.50% 
0%
20%
40%
60%
80%
100%
120%
92 
 
                                 CLINICAL PROGNOSIS 
S.No SIGNS& 
SYMPTOMS 
BEFORE TREATMENT AFTER TREATMENT 
NO.OF 
CASES 
PERCENTAGE 
(%) 
NO.OF 
CASES 
PERCENTAGE 
(%) 
1. Flank pain 40 100% 9 12.5% 
2 Nausea 3 7.5% 1         2.5% 
3 Vomiting 1 2.5% 0 0% 
4 Burning Micturition 20 50% 5 12.5% 
5 Dysuria 8 20% 2 5% 
6 Retention 1 2.5% 0 0% 
7 Hematuria 3 7.5% 0 0% 
 
 
            
 
 
INFERENCE 
 
 After treatment Flank pain present in 5 patients (12.5%), nausea present in one 
patient  (2.5%), Burning Micturition present in 5patient (12.5%), Dysuria present in 2 
patients (5%). 
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DISTRIBUTION OF CALCULI BASED ON LOCATION 
 
SIDE BEFORE TREATMENT AFTER TREATMENT 
NO.OF 
CASES 
PERCENTAGE 
(%) 
NO.OF 
CASES 
PERCENTAGE 
(%) Rt – Kidney 13 32.5% 10 25%
Lt – Kidney 5 12.5% 1 2.5% 
Bilateral 20 50% 14 35% 
Ureteral 2 5% 1 2.5% 
 
       
         
 
 
DISTRIBUTION OF CALCULI BASED ON LOCATION 
 
INFERENCE 
 
  Before treatment:Out of 40 patients, 20 patients (50%) were having bilateral renal 
calculi, 13 patients (32.5%) were having right renal calculi, and 5 patients (12.5%) were 
having left renal calculi, 2 patients were having ureteric calculi. 
After treatment: 
 Out of 40 patients, 14 patients (35%) were having bilateral renal calculi, 10 
patients (25%) having right renal calculi and 1 patient (2.5%) having left renal calculi, 1 
patient (2.5%) having ureteric calculi. 
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                                      GRADING OF RESULTS 
 
 
 
S.NO 
 
NO OF 
CASES 
 
 
  BEFORE TREATMENT 
AFTER TEATMENT 
Expelsion of 
calculi 
Size reducing of 
calculi 
1     6                      4 mm- 5mm    4patients 3mm, 3.5mm 
2    8  5 mm- 6mm    5 patients 3mm,4mm,5mm. 
3     3  6 mm-7mm   1 patient. 3mm, 5mm. 
4     1  7 mm-8mm  3.2mm 
5     5  8 mm-9mm  5mm,7mm,3.1mm, 
7mm,8mm. 
6     1  10 mm    1 patient  
7     1 11 mm  4mm 
8    15 Multiple stones     3 patients  12 patients has size 
reducing of calculi. 
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                                  GRADING OF RESULTS 
 
 
S.No GRADING NUMBER OF CASES PERCENTAGE (%) 
1 Good 24 60% 
2 Moderate 10 25% 
 
 
Poor 6 15% 
 
 
 
       
 
 
 
INFERENCE 
  
Out of 40 patients, 24 cases (60%) shows good result, 10 cases (25%) shows 
moderate result, 6 cases (15%) shows poor result. 
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LIST OF PATIENTS 
 
S.no Op. no Patient’s name Age/Sex Occupation Date of 
Medicine 
Started 1 5893 Mr. Karnan 37/M Coolie 02-02-15 
2 6705 Mr. Udhaya prakash 27/M Engineer 06-02-15 
3 8669 Mr. Ragavan 44/M Clerk 18-02-15 
4 271 Mr.Rjesh 25/M Coolie 27-02-15 
5 9055 Mrs.Anjammal 56/F Housewife 05-03-15 
6 3300 Mr.Vengateshan 31/M Electrician 18-03-15 
7 1546 Mrs.Lalitha 28/M housewife 15-04-15 
8 1723 Mrs.Selvi 49/F Tailor 16-04-15 
9 2846 Mrs. Malliga 44/F House wife 20-04-15 
10 2805 Mr.Dinesh kumar 20/M Student 20-04-15 
11 4176 Mr. Vasudevan 59/M Teacher 24-04-15 
12 9182 Mr.Mogamed 26/M Clerk 12-05-15 
13 2623 Mrs. Indira 31/F Housewife 29-06-15 
14 3288 Mrs.Amirthavalli 34/F Housewife 01-07-15 
15  3787 Mrs. Kanagavalli 52/F Doctor 02-07-15 
16 7792 Mr.Rajen 32/M Coolie 16-07-15 
17 5469 Mr.Sigamani 43/M Mechanic 12-08-15 
18 9907 Mr. Amulraj 43/M Painter 28-08-15 
19 9126 Mrs.Jeyabharathi 35/F Teacher 03-11-15 
20 1651 Mrs.Sundari 30/F IT Profession 06-01-16 
21 2186 Mr.Jeyachandran 46/M Farmer 16-01-16 
22 5220 Mrs.Lalitha 30/F Teacher 20-01-16 
23 6456 Mrs. Bavya 35/F House wife 24-01-16 
24 6455 Mrs.Anitha 33/F IT profession 24-01-16 
25 6880 Mr.Soundarrajen 31/M Bank officer 25-01-16 
26 7582 Mrs. Rajeshwari 36/F House wife 27-01-16 
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27 9414 Mr. Rajaram 33/M Teacher 1-02-16 
28 9711 Mr.Kumar 37/M Coolie 02-02-16 
29 1727 Mr.Babu suresh 49/M Office work 08-02-16 
30 1935 Mrs.Umamaheshwari 30/F Housewife 08-02-16 
31 4590 Mrs.Shanthi 52/F Tailour 16-02-16 
32 5736 Mrs.Geetha 52/F Housewife 18-02-16 
33 6226 Mr. Murali 44/M Farmer 20-02-16 
34 6912 Mr.Ranganathan 60/M Watchmen 23-02-16 
35 7167 Mrs.Rajeshwari 36/F Business 23-02-16 
36 7498 Mr.Deena dhayalan 38/M Clerk 24-02-16 
37 7732 Mr. Rajasekar 45/M Auto driver 24-02-16 
38 9213 Mrs.Jeyanthi 42/F Tailour 29-02-16 
39 4885 Mr.Vivegananthar 45/M Driver 17-03-16 
40 6097 Mr Shanmugasundaram 46/M Farmer 21-03-16 
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S.N
o 
Name of the 
patient 
 
Age/S
ex 
Date of 
Treatment 
Started 
Duration of 
medicine 
taken 
Size of stone 
BT 
Prognosis Remarks 
1 Mr. Karnan 37/M 02-02-15 7- Weeks LT ureter- 
11mm 
 LT- 4mm Symptoms reduced 
2 Mr. Udhaya 
prakash 
27/M 06-02-15 7- Weeks Bilateral 4.5 
mm 
USG Normal Completed 
3 Mr. Ragavan 44/M 18-02-15 7- Weeks Bilateral RT -
3mm, LT-3mm 
 USG Normal Symptoms reduced 
4 Mr.Rjesh 25/M 27-02-15 7- Weeks RT 7.3mm RT 3.2mm Symptoms reduced 
5 Mrs.Anjammal 56/F 05-03-15 7- Weeks RT  (5 mm) USG Normal Symptoms reduced 
6 Mr.Vengateshan 31/M 18-03-15 5- Weeks Bilateral  
Muliple 
calculi(5mm) 
 RT 5mm, LT 
3 (4mm,3mm) 
Advice to continue 
medicine 
7 Mrs.Lalitha 28/M 15-04-15 7- Weeks RT 5mm USG Normal Symptoms relieved 
8 Mrs.Selvi 49/F 16-04-15 7- Weeks RT (10mm, 
9mm) 
RT 3mm Symptoms relieved 
9 Mrs. Malliga 44/F 20-04-15 7- Weeks  RT  (8mm) RT  (5mm) Symptoms reduced 
10 Mr.Dinesh kumar 20/M 20-04-15 7- Weeks  Bilateral -RT2( 
6mm) LT 
multiple(5mm) 
RT 2(4mm), 
LT 3 (4.5mm, 
4mm, 3mm) 
Symptoms reduced 
11 Mr. Vasudevan 59/M 24-04-15 7- Weeks Bilateral LT 
9mm, 1.1cmRT  
5mm 
LT 9mm, RT 
3mm 
Symptoms reduced 
12 Mr.Mogamed 26/M 12-05-15 7- Weeks LT 6mm 5mm Symptoms relieved 
13 Mrs. Indira 31/F 29-06-15 7- Weeks Bilateral RT 
8mm, LT 8mm 
RT 3mm, LT 
3mm 
Symptoms reduced 
14 Mrs.Amirthavalli 34/F 01-07-15 7- Weeks  RT (4mm) RT(3.5mm) Symptoms reduced 
15 Mrs. Kanagavalli 52/F 02-07-15 7- Weeks LT ureter -5mm LT-4mm Symptoms reduced 
16 Mr.Rajen 32/M 16-07-15 7- Weeks LT-6mm  Stone Symptoms relieved 
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expelled 
17 Mr.Sigamani 43/M 12-08-15 7- Weeks  RT 5 mm USG Normal Symptoms  reduced 
18 Mr. Amulraj 43/M 28-08-15 7- Weeks LT- 5mm  LT 3mm . Symptoms  relieved 
19 Mrs.Jeyabharathi 35/F 03-11-15 7- Weeks LT - 9mm,3mm LT- 3mm Symptoms  reduced 
20 Mrs.Sundari 30/F 06-01-16 7- Weeks RT  (4.5mm) USG Normal Symptoms  relieved 
21 Mr.Jeyachandran 46/M 16-01-16 7- Weeks Bilateral    RT- 
4.1mm , LT-
4.2mm 
RT 4mm. Symptoms  relieved 
22 Mrs.Lalitha 30/F 20-01-16 7- Weeks RT  10mm Stone 
expelled 
Completed 
23 Mrs. Bavya 35/F 24-01-1R6 7- Weeks RT  (8.5mm) RT  (7mm) Symptoms  relieved 
24 Mrs.Anitha 33/F 24-01-16 7- Weeks RT 8mm RT 8mm Symptoms  relieved 
25 Mr.Soundarrajen 31/M 25-01-16 7- Weeks  Bilateral RT 
4(5mm),         
LT 2(4, 3mm) 
RT 3 mm, 
4mm 
Symptoms  reduced 
26 Mrs. Rajeshwari 36/F 27-01-16 7- Weeks LT 5mm USG Normal Symptoms reduced 
27 Mr. Rajaram 33/M 1-02-16 7- Weeks RT (4.6mm) RT  (3mm) Symptoms relieved 
28 Mr.Kumar 37/M 02-02-16 7- Weeks Bilateral RT 3 
(6mm,3mm,3m
m) LT 
multiple(5mm) 
RT 3 (3mm), 
LT 2 (3.5mm) 
Symptoms reduced 
29 Mr.Babu suresh 49/M 08-02-16 7- Weeks RT 6 mm RT (3mm) Symptoms  reduced 
30 Mrs.Umamahesh
wari 
30/F 08-02-16 7- Weeks Bilateral RT 
(8.5mm), LT 
(8.5mm) 
RT (3mm), 
LT  (3.5mm) 
Symptoms  reduced 
31 Mrs.Shanthi 52/F 16-02-16 7- Weeks LT  (8.7mm) 7mm Symptoms   relieved( 
32 Mrs.Geetha 52/F 18-02-16 7- Weeks  RT  (4.9mm), USG Normal Symptoms  relieved 
33 Mr. Murali 44/M 20-02-16 7- Weeks Bilateral 
RT(4mm), LT 
(7mm)  
USG Normal Symptoms  relieved 
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34 Mr.Ranganathan 60/M 23-02-16 7- Weeks  RT 2 
(5mm,9mm),  
RT 2 
(4mm,5mm),  
Symptoms  reduced 
35 Mrs.Rajeshwari 36/F 23-02-16 7- Weeks Bilateral RT4 
(3mm),LT(4mm
) 
USG Normal Symptoms  reduced 
36  Mr.Deena 
dhayalan 
38/M 24-02-16 8- Weeks  LT 5mm USG Normal Completed 
37 Mr. Rajasekar 45/M 24-02-16 7- Weeks RT 4.2mm Stone 
expelled 
Symptoms reduced 
38 Mrs.Jeyanthi 42/F 29-02-16 7- Weeks LT 4mm,  USG Normal  Completed 
39 Mr.Vivegananthar 45/M 17-03-16 7- Weeks RT 8 mm 3.1mm Symptoms  reduced 
40 Mr 
Shanmugasundara
m 
46/M 21-03-16 7- Weeks  LT 5 mm 5mm Symptoms  relieved 
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                                                                   LABORATORY  INVESTIGATION  REPORT    
                                                             
 
                                                                                BEFORE TREATMENT                                                                                                                                             
 
 
 
S.N
o 
 
 
OP.N
o 
 
 
Name 
 
 
Age/
Sex 
Haematological report RFT  Urine Analysis 
 
TC 
cells/ 
cu.m
m 
 
DC 
% 
  
 
ESRm
m 
 
Hb 
gms
% 
 
Urea 
mg/dl 
 
Creatin
ine 
mg/dl 
 
 
Alb 
 
Sug 
 
Dep 
 P L E ½ hr 1 hr        
1 5893 Mr. Karnan 37/M 9400 57 39 4 7 13 11 32 0.6  Nil Nil Opc 
2 6705 
Mr. Udhaya 
prakash  
27/M 8400 54 42 4 6 15 10.2 31 1.0  Nil Nil Opc 
3 8669 Mr. Ragavan 44/M 8000 57 39 4 5 15 12.6 34 0.9  Nil Nil Oec 
4 271 Mr.Rjesh 25/M 9300 52 45 3 12 25 11 29 1.0  + Nil Opc 
5 9055 Mrs.Anjammal 56/F 8900 60 37 3 7 12 10.2 29 0.8  Nil Nil Oec 
6 3300 Mr.Vengateshan 31/M 9200 57 41 2 10 27 9.6 31 0.6  Nil Nil Nil 
7 1546 Mrs.Lalitha 28/M 9200 60 36 4 10 26 11.9 29 0.9  Nil Nil Nil 
8 1723 Mrs.Selvi 49/F 8800 61 35 4 6 15 10.2 24 1.0  Nil Nil Oec 
9 2846 Mrs. Malliga 44/F 8400 53 41 6 15 26 13.4 26 0.5  Nil Nil Nil 
10 2805 Mr.Dinesh kumar 20/M 8900 51 43 6 17 30 12.8 28 0.7  Nil Nil Opc 
11 4176 Mr. Vasudevan 59/M 8300 60 35 5 10 22 8.7 27 0.8  Nil Nil Oec 
12 9182 Mr.Mogamed 26/M 9600 59 38 3 17 25 13 29 1.2  Nil Nil Oec 
13 2623 Mrs. Indira 31/F 8200 61 35 4 8 15 10.6 28 0.8  Nil Nil Oec 
14 3288 Mrs.Amirthavalli 34/F 8300 59 37 4 6 12 9.9 26 0.7  Nil Nil Nil 
15 3787 Mrs. Kanagavalli 52/F 8900 46 49 5 12 30 10.2 29 0.9  Nil Nil Oec 
16 7792 Mr.Rajen 32/M 9000 56 39 5 9 16 13 27 0.9  Nil Nil Opc 
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TC – Total count, DC – Differential count, P – Polymorphs, L – Lymphocyte, E – Eosinophil, ESR – Erythrocyte Sedimentation Rate, 
Oe 
17 5469 Mr.Sigamani 43/M 8800 55 42 3 11 25 13.5 22 0.9  + Nil Opc 
18 9907 Mr. Amulraj 43/M 9000 51 44 5 19 25 11.9 27 0.6  Nil ++ Opc 
19 9126 Mrs.Jeyabharathi 35/F 8900 60 37 3 10 22 13.8 26 0.9  Nil Nil Opc 
20 1651 Mrs.Sundari 30/F 9200 58 39 3 8 16 10 30 1.1  Nil Nil Opc 
21 2186 Mr.Jeyachandran 46/M 9400 56 39 5 11 27 14.5 29 0.8  Nil + Opc 
22 5220 Mrs.Lalitha 30/F 9100 54 41 5 13 32 12.7 26 0.9  Nil Nil Opc 
23 6456 Mrs. Bavya 35/F 8500 56 39 5 9 27 10.1 31 1.2  Nil Nil Oec 
24 6455 Mrs.Anitha 33/F 7200 51 42 7 25 40 11.8 39 1.3  Nil Nil Oec 
25 6880 Mr.Soundarrajen 31/M 6700 47 45 8 8 13 12.9 35 0.9  Nil Nil Oec 
26 7582 Mrs. Rajeshwari 36/F 8000 52 42 6 25 49 12 36 1.8  Nil Nil Nil 
27 9414 Mr. Rajaram 33/M 8200 53 42 5 17 29 14 31 1.4  Nil Nil Opc 
28 9711 Mr.Kumar 37/M 7300 54 40 6 12 28 13 28 0.7  Nil Nil Opc 
29 1727 Mr.Babu suresh 49/M 6500 51 44 5 7 15 10.1 28 1.2  Nil Nil Nil 
30 1935 
Mrs.Umamaheshw
ari 
30/F 
1000
0 
60 36 4 19 37 12.6 35 1.1  Nil Nil Oec 
31 4590 Mrs.Shanthi 52/F 8500 63 34 3 22 59 13.0 32 1.3  Nil ++ Opc 
32 5736 Mrs.Geetha 52/F 9100 64 34 2 4 19 7.8 34 0.8  Nil Nil Opc 
33 6226 Mr. Murali 44/M 8100 58 39 3 23 57 12.6 23 0.8  + Nil Nil 
34 6912 Mr.Ranganathan 60/M 8500 63 34 3 18 43 10.7 24 1.0  Nil Nil Oec 
35 7167 Mrs.Rajeshwari 36/F 9000 58 36 6 16 37 14.9 27 0.8  Nil Nil Nil 
36 7498 
Mr.Deena 
dhayalan 
38/M 8700 60 36 4 2 9 8.9 37 1.0  Nil Nil Opc 
37 7732 Mr. Rajasekar 45/M 9200 56 39 5 28 54 14.2 34 1.3  Nil Nil Opc 
38 9213 Mrs.Jeyanthi 42/F 9000 58 40 2 13 43 12.9 30 0.8  Nil Nil Opc 
39 4885 Mr.Vivegananthar 45/M 7900 56 42 2 6 21 14.9 35 0.9  Nil + Oec 
40 6097 
Mr.Shanmugasund
aram 
46/M 6300 63 32 5 16 29 15 26 0.7  Nil Nil Opc 
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                                                               LABORATORY INVESTIGATION REPORT 
 
  AFTER TREATMENT 
 
        
 
 
S.N
o 
 
 
OP.No 
 
 
       Name 
 
 
Age/S
ex 
Haematological report RFT Urine Analysis 
 
TC 
cells/ 
cu.m
m 
 
DC 
% 
   
ESR 
 Hb 
gms
% 
 
Urea 
mg/ 
dl 
 
Creati
nine 
mg/dl 
 
Alb 
 
Sug 
 
Dep 
 P L E ½ hr 1 hr       
1 5893 Mr. Karnan 37/M 9500 59 36 5 6 13 11.8 27 0.7 Nil Nil Nil 
2 6705 Mr. Udhaya prakash 27/M 8000 55 41 4 7 18 12 22 0.9 Nil Nil Nil 
3 8669 Mr. Ragavan 44/M 8100 56 40 4 9 15 14.3 25 0.9 Nil Nil Nil 
4 271 Mr.Rjesh 25/M 9500 59 37 4 10 23 12 25 0.8 Nil Nil Nil 
5 9055 Mrs.Anjammal 56/F 8800 60 36 4 8 15 10.1 26 0.6 Nil Nil Oec 
6 3300 Mr.Vengateshan 31/M 9300 57 40 3 3 8 10.4 29 0.9 Nil Nil Nil 
7 1546 Mrs.Lalitha 28/M 7700 51 45 4 9 16 11.. 27 0.8 Nil Nil Nil 
8 1723 Mrs.Selvi 49/F 8100 64 32 4 7 15 11 28 1.0 Nil Nil Nil 
9 2846 Mrs. Malliga 44/F 7000 64 31 5 5 14 10.4 27 0.8 Nil Nil Nil 
10 2805 Mr.Dinesh kumar 20/M 8200 59 36 5 10 20 14.1 26 0.8 Nil Nil Nil 
11 4176 Mr. Vasudevan 59/M 8500 63 34 3 11 25 8.9 28 0.9 Nil Nil Opc 
12 9182 Mr.Mogamed 26/M 8200 56 40 4 7 13 15 28 0.6 Nil Nil Nil 
13 2623 Mrs. Indira 31/F 9000 64 33 3 5 15 10.2 27 0.8 Nil Nil Nil 
14 3288 Mrs.Amirthavalli 34/F 9300 56 39 5 12 19 11.8 28 0.9 Nil Nil Nil 
15 3787 Mrs. Kanagavalli 52/F 8600 55 41 4 13 25 10.7 24 0.7 Nil Nil Opc 
16 7792 Mr.Rajen 32/M 8000 62 35 3 4 9 12.2 21 0.8 Nil Nil Nil 
17 5469 Mr.Sigamani 43/M 7900 56 40 4 7 15 12 24 0.8 Nil Nil Nil 
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18 9907 Mr. Amulraj 43/M 8400 63 34 3 9 12 11.1 23 0.7 Nil + Nil 
19 9126 Mrs.Jeyabharathi 35/F 8800 57 40 3 8 17 11 28 0.9 Nil Nil Opc 
20 1651 Mrs.Sundari 30/F 7200 57 39 4 5 13 14 29 0.9 Nil Nil Nil 
21 2186 Mr.Jeyachandran 46/M 9300 51 45 4 5 12 13.4 21 0.6 Nil + Nil 
22 5220 Mrs.Lalitha 30/F 8400 60 35 5 7 12 10.2 27 0.8 Nil Nil Nil 
23 6456 Mrs. Bavya 35/F 8100 53 42 5 9 17 10.8 23 1.0 Nil Nil Nil 
24 6455 Mrs.Anitha 33/F 7500 56 40 4 10 24 12.0 27 0.6 Nil Nil Opc 
25 6880 Mr.Soundarrajen 31/M 7900 57 38 5 5 13 12.9 26 0.9 Nil Nil Nil 
26 7582 Mrs. Rajeshwari 36/F 8400 59 38 3 15 25 10.4 32 1.3 Nil Nil Nil 
27 9414 Mr. Rajaram 33/M 9600 58 38 4 13 21 14 30 1.0 Nil Nil Nil 
28 9711 Mr.Kumar 37/M 7200 63 34 3 8 19 12 25 0.9 Nil Nil Nil 
29 1727 Mr.Babu suresh 49/M 8200 56 38 6 6 10 10.8 27 0.8 Nil Nil Nil 
30 1935 Mrs.Umamaheshwari 30/F 8900 60 35 5 5 14 12.9 22 1.0 Nil Nil Nil 
31 4590 Mrs.Shanthi 52/F 8300 59 38 3 8 14 13.7 30 1.0 Nil ++ Opc 
32 5736 Mrs.Geetha 52/F 8300 60 35 5 13 27 12.6 28 0.9 Nil Nil Nil 
33 6226 Mr. Murali 44/M 9100 58 39 3 4 11 10.1 25 0.7 + Nil Nil 
34 6912 Mr.Ranganathan 60/M 8100 60 37 3 11 26 10.4 27 0.9 Nil Nil Nil 
35 7167 Mrs.Rajeshwari 36/F 6900 58 38 4 7 12 13.9 26 0.8 Nil Nil Nil 
36 7498 Mr.Deenadayalan 38/M 8800 53 44 3 5 16 13.8 25 0.9 Nil Nil Nil 
37 7732 Mr. Rajasekar 45/M 8200 50 45 5 7 17 10.6 23 0.8 Nil Nil Nil 
38 9213 Mrs.Jeyanthi 42/F 9000 57 40 3 3 8 12.4 28 0.8 Nil Nil Oec 
39 4885 Mr.Vivegananthar 45/M 8100 59 38 3 4 9 14.5 27 0.6 Nil Nil Nil 
40 6097 Mr 
Shanmugasundaram 
46/M 9300 53 44 3 15 28 15 29 0.8 Nil Nil Nil 
 – Occasional epithelial cells, Opc – Occasional pus cells, Alb – Albumin, Sug – Sugar, Dep – Deposits.  
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DISCUSSION 
KALLADAIPPU is a common disease pertaining to the kidney. Large populations are 
suffering from this disease. But they are not completely relieved from their symptoms by other 
systems of medicine. Hence with the help of trial medicine from Siddha system, results and 
observations are noted for this study. 
 The patients were examined base on Siddha and as well as modern aspects. All the 
necessary investigations were made during the study. The results obtained from their studies were 
discussed below for better conclusion. 
 Trial medicine administered was vediyuppu chendooram – 130-260mg 2 times a day with 
mullangi kizhangu chaaru after food for 48 days. 
1. Sex distribution: 
Among 40 cases 23 were males and 17 were females. 
2. Age distribution: 
Although all the decades of people are affected 35% were affected in 3
rd
 decade, 
30% were affected in 4
th
 decade. 
3. Occupation : 
40% were affected in office worker, 22.5% were affected in Farmer, 20% were affected in 
House wife. 
Mixed categories of people are affected, from housewife to working woman,  
students to retired person. House wives and office workers were affected 
commonly. 
4. Food habits: 
Among 40 patients, 10 patients eat vegetarian food and others eat mixed diet. 
5. According to season: 
The highest incidence were noted in pinpani kaalam (52.5%) and 17.5% were noted 
in munpani Kaalam. This shows that due to hot climate, majority of the people have been 
reported during this period. 
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6. Distribution of thinai: 
According to thinai, the highest distribution 70% was noted in neithal, 15% in 
Marutham and 12.5% noted in kurinji. 
7. On clinical manifestations: 
All of my patients were present one or more urinary symptoms, 100% were having 
flank pain, 50% were having burning Micturition,20% were having dysuria, 7.5% had 
nausea and hematuria, 5% had Oliguria and 2.5% had vomiting and urine retention. 
8. Mukkutram: 
Distribution of vatham: 
 Among the patients 100% were affected in Abanan,Viyanan and Samanan, 30% in 
Devathathan, 20% in Kirukaran and 10% in Koorman and udhanan. 
     Affected Abanan produced burning Micturition, constipation and hematuria. 
    Affected viyanan produce difficulty in movements.  
    Affected Samanan produced indigestion. 
    Affected Uthanan produced nausea and vomiting. 
    Affected Koorman produced impairment of eye sight 
    Affected Kirukaran produced loss of appetite.  
              Affected Devathathan produced loss of  
   
Distribution of pitham: 
Among the treated patients 100% were affected in Saathagam,  22.5% were 
affected in Ranjagam, 12.5% in Analagam, and 10% were affected in alosagam. 
 The affected Analagam produced loss of appetite. 
 Affected Ranjagam produced pallor of skin, eye and reduced hemoglobin. 
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       Affected Saathagam produced difficulty in doing routine work 
 Affected Alosagam produced impairment of eye sight 
Distribution of Kabham: 
Among the patients, 45% were affected in Santhigam, 12.5% affected in kiletham, 
10% affected in pothagam and tharpagam, 2.5% affected in Avalambagam. 
 Affected Klethagam produced loss of appetite. 
 Affected Santhigam produced low back pain, knee joint pain. 
            Affected pothagam produced loss taste. 
            Affected tharpagam produced impairment of eye sight. 
            Affected avalambagam produced dyspnea. 
9. Ezhu Udal Thathukkal: 
Among the treated patients saram was affected in 100% of patients, Enbu was 
affected in 32.5% and senheer in 25%, oon was affected in 2.5%. 
10.  Enn vagai thervugal:  
In this, Moothiram was affected in 65%, Mozhi was affected in 25%, Sparisam in  
         12.5%, Malam in12.5% and Vizhi in 10%, Naa was affected in 5% 
11. Naadi: 
 On examination of naadi, 30% had vazhiazhal naadi, 5% had vali Iyam, 52.5%%  
        had azhal vali naadi, 5% had kabha vatha naadi and 7.5% had kabha pitha naadi. 
12. Neikuri: 
On Neikuri examination 55% were having vatha neer, 30% were having pitha neer 
and 15% were having kabha neer. 
A drop of gingely oil dropped into the early morning urine sample in a bowl may 
result in spread like snake called vatham, like a ring in pitham, like pearl in kabham. 
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13.  Urinary calculi based on location: 
In total 40 patients 20 were having bilateral stones (50%), 13 were having right side 
stone (32.5%) and 5 were having left side stone (12.5%), 2 were having ureteric calculi. 
This shows that the ureteric calculi are easily pushed out by Allopathic treatments 
and the people with calculi in the kidney approaches siddha system for a permanent relief. 
14. Special investigation: 
USG- abdomen and pelvis is advised for all the patients to confirm the diagnosis. 
After confirming the diagnosis, the patients were given the trial medicine and 
instructed to follow the diet and other restrictions based on Siddha system. 
15.  Urine analysis: 
It was observed that, 40% of cases showed pus cells in urine. 
 
16. Mode of action of the drug: 
According to suvai: 
The trial medicine Vediyuppu chendooram has astringent taste. 
This taste will equalize the increased pitham which is the main cause for 
Kalladaippu. This medicine acts against the increased pitham. So it is considered as 
Ethirurai maruthuvam. 
       According to veeriyam: (nature) 
The trial medicine Vediyuppu chendooram possesses thatpa veeriyam. So it cures 
pitha diseases.    By this Vediyuppu chendooram treats Kalladaippu noi. 
17.  Bio chemical analysis: 
Vediyuppu chendooram  has Chloride, magnesium,  Flouride and iron. 
18. Toxicological analysis: 
Acute and Sub acute toxicity studies were conducted at Baid metha   College of 
Pharmacy. At the end of toxicity studies the hematological parameters (TC, DC and Hb), 
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Biochemical parameters (LFT, KFT) and histopathology of vital organs like Liver, Kidney, 
Spleen and Lungs were carried out. Vediyuppu chendooram shows no toxic effect. 
 
19. Pharmacological analysis: 
Pharmacological studies of the trial medicine Vediyuppu  chendooram  showed 
Lithotriptic actions in albino wistar rats. 
The results of preclinical screening, the results of Chemical analysis, Toxicological 
studies, Pharmacological studies are shown in annexures. 
 
20. Statistical analysis: 
The preclinical studies of trial medicine Vediyuppu  chendooram statistically 
analysed and showed significant result. 
Statistical analysis of clinical study were done for the subjective and objective 
parameter, observed before and after treatment statistical results of preclinical and clinical 
study were attached to annexure. 
 
21. Results after treatment: 
Many of the patients were relieved of their problem, 60% showed good result that 
is both by symptoms and by Sonographic findings, 25% showed moderate result who are 
relieved of their symptoms and reduction in stone size, 15% showed poor result were not 
relieved of their problem. 
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                                           SUMMARY 
 
 I like to summarize this study with the following highlights. 
 Males are more prone to get kalladaippu than females according to my studies. 
 In age distribution, 3rd and 4th decades of people are more affected. 
 Office workers and House wives occupy the first two places in occupational classification. 
 Most of the patient had mixed diet. 
 Higher incidence of cases were noted in pinpani kalam. 
 In the disturbance of Ezhu udal thathukkal, 100% were affected by saaram,  32.5% were 
affected by enbu and 25% were affected in seneer. 
 In Naadi, most of the patients having 52.5% in azhal vali naadi, 30% in vali azhal naadi. 
 In Neikuri examination 55% were having vatha neer. 
 Among the patients, 100% had flank pain, 50% had burning Micturition, and 20% had 
Dysuria. 
  50% patient had bilateral renal calculi, 32.5% patient had right renal calculi. 
 All of my patients were administered with my trial medicine Vediyuppu chendooram– 130- 
260 mg bd with mullangi kizhangu chaaru after food for a period of 48 days. 
 After treatment with this trial medicine, most of the symptoms like loin pain, burning 
Micturition and Dysuria are relieved. The trial medicine shows 60% good result and 25% 
moderate result and 15% poor result. 
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                                           CONCLUSION 
 
 Kalladaippu is a common disorder of pitha kutram. The dearranged pitham is settled down 
by the trial medicine having astringent taste thereby the medicine acts as ethirurai 
maruthuvam to cure the disease. 
 Most of the cases noted in pinpani kalam and munpani kalam in my clinical trial. So, 
people should take all preventive measures during this period and take enough water. 
 Toxicological study shows no acute and sub acute toxicity. 
 Pharmacological study reveals that the trial medicines possess lithotriptic activity. 
 During clinical trial, no adverse reactions or complications were observed. 
 The palatability of the trial drug is astringent, so it is easier to consume to the patients. 
The trial medicine Vediyuppu chendooram showed good results with relieving symptoms in 
almost 85% patients. 
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BIO-CHEMICAL ANALYSIS OF TRIAL MEDICINE 
 
       Preparation of Sodium Carbonate extract: 
 
     2 gm of the sample drug is mixed 5 gm of Sodium carbonate and taken in a 100 ml 
beaker and 20 ml of distilled water is  added. The solution is boiled for 10 minutes, cooled and 
then filtered. The filtrate is called sodium carbonate extract. 
   
 
S.No EXPERIMENT OBSERVATION INFERENCE 
I                                    TEST FOR ACID RADICALS 
1a Test for Sulphate 
2 ml of the above prepared extract is 
taken in a test tube. To this add 2ml of 
4% Ammonium oxalate solution. 
Absence of 
White Precipitate 
Absent 
B 2ml of extract is added with 2ml 
of dilute hydrochloric acid until 
the effervescence ceases off. Then 2ml 
barium chloride solution is added. 
Absence of 
White Precipitate 
Absent 
2 Test for Chloride: 
2ml of extract is added with dilute 
nitric acid till the effervescence ceases. 
Then 2ml of silver nitrate solution is 
added. 
white precipitate 
obtained 
Present 
3 Test for Phosphate 
2ml of the extract is treated with  
2 ml of Ammonium molybdate solution 
and 2ml of concentrated nitric acid. 
 
Absence of Yellow 
precipitate 
 
Abscent  
4 Test for Carbonate: 
2ml of the extract is treated with 2ml of 
magnesium sulphate solution. 
Absence of white 
Precipitate 
Absent 
5 Test for Sulphide: 
1 gm of the substance is treated 
with 2ml of concentrated Hcl. 
Absence of Rotten 
egg smelling 
Absent 
6 Test for Nitrate: 
1gm of the substance is heated with 
copper turnings and concentrated 
sulphuric acid and viewed the test tube 
Absence of reddish 
brown gas. 
Absent 
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vertically down. 
7a Test for Fluoride and oxalate 
2ml of the extract is added with 2ml of 
dilute acetic acid and 2ml of calcium 
chloride solution and heated. 
Absence of white 
Precipitate 
Absent 
B 5 drops of clear solution is added with 
2ml of diluted sulphuric acid and 
slightly warmed to this, 1 ml of dilute 
potassium permanganate 
solution is added. 
KMNO4 solution 
Discolourisation 
obtained 
Present 
8 Test for Nitrite 
3 drops of the extract is placed on a 
filter paper. On that, 2 drops of Acetic 
Acid and 2 drops of Benzidine solution 
is placed. 
Absence of 
yellowish red colour 
Absent 
9 Test for Borate 
2 pinches of the substance is made into 
paste by using Sulphuric acid and 
Alcohol (95%) and introduced into the 
blue flame. 
Absence of Green 
tinged flame 
Absent 
II TEST FOR BASIC RADICALS 
10 Test for lead 
2 ml of the extract is added with 2 ml 
of Potassium iodide solution. 
Absence of Yellow 
Precipitate 
Absent 
11a Test for Copper 
One pinch of substance is made into 
paste with concentrated Hydrochloric 
acid in a watch glass and introduced 
into the non luminous part of the flame. 
Absence of Bluish 
green coloured 
flame. 
Absent 
B 2ml of the extract is added with excess 
of Ammonia solution 
 
Absence of deep 
Blue 
Absent 
12 Test for Aluminium 
To the 2 ml of extract. Sodium 
Hydroxide solution is added in drops to 
excess 
Absence of White 
Precipitate. 
Absent 
13a Test for Iron 
To the 2 ml of extract, 2 ml of 
Ammonium Thiocyanate Solution is 
added. 
Absence of Blood 
red colour 
Absent 
B To the 2 ml of extract, 2 ml of Blood red colour Present 
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Ammonium Thiocyanate solution and 2 
ml of concentrated Nitric Acid is 
added. 
obtained 
14 Test for Zinc 
To the 2 ml of extract Sodium 
Hydroxide solution is added in drops to 
excess. 
 
Absence of White 
precipitate. 
Absent 
15 Test for Calcium 
2 ml of the extract is added with 2 ml 
of 4% Ammonium Oxalate solution. 
Absence of White 
precipitate. 
Absent 
16 Test for Magnesium 
2ml of extract, Sodium Hydroxide 
solution is added in drops to excess. 
Absence of White 
precipitate. 
Absent 
17 Test for Ammonium 
2 ml of extract few ml of Nessler’s 
Reagent and excess of Sodium 
Hydroxide solution are added. 
Absence of 
Reddish brown 
Precipitate 
Absent 
18 Test for Potassium 
A pinch of substance is treated with 2 
ml of Sodium Nitrite solution and then 
treated with 2 ml of Cobal Nitrate in 
30% glacial Acetic acid. 
Absence of Yellow 
precipitate 
 
Absent 
19 Test for Sodium 
2 pinches of the substance is made into 
paste by using Hydrochloric acid and 
introduced into the blue flame. 
 
Absence of Yellow 
colour flame 
Absent 
20 Test for Mercury 
2 ml of the extract is treated with 2 ml 
of Sodium Hydroxide solution. 
Absence of yellow 
Precipitate 
Absent 
21 Test for Arsenic 
2 ml of extract is treated with 2 ml of 
silver Nitrate solution. 
Absence of 
Yellow precipitate 
Absent 
22 Test for Starch 
2ml of extract is treated with weak 
iodine solution 
Absence of 
Blue colour 
Absent 
23 Test of reducing Sugar 
5ml of Benedicts qualitative solution is 
taken in a test tube and allowed to boil 
Absence of Green 
colour 
Absent 
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for 2 minutes and added 10 drops of the 
extract and again boiled for 2 minutes. 
The colour changes are noted. 
24 Test of the alkaloids 
2ml of the extract is treated with 2ml of 
potassium lodide solution. 
Absence of 
Red colour 
Absent 
25 Test of the proteins 
2ml of the extract is treated with 2ml of 
5% NaOH, mix well and add 2 drops of 
copper sulphate solution. 
Absence of 
Violet colour 
Absent 
 
RESULTS: 
The given sample (vediyuppu chendooram) contains  
Chloride 
            Flouride  
Iron. 
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ACUTE ORAL TOXICITY – OECD GUIDELINES - 423  
Acute toxicity study was carried out as per OECD guideline (Organization for 
Economic Co - operation and Development, Guideline-423 
Animal : Healthy wistar albino female rat weighing 200–220 gm 
Studied carried out at three female rat under fasting condition, signs of 
toxicity was observed for every one hour for first 24 hours and every day for about 
14 days from the beginning of the study. 
INTRODUCTION:  
The acute toxic class method is a stepwise procedure with the use of 3 
animals of a single sex per step. Depending on the mortality and/or the moribund 
status of the animals, on average 2-4 steps may be necessary to allow judgment on 
the acute toxicity of the test substance. Morbid animals or animals obviously in pain 
or showing signs of severe and enduring distress shall be humanely killed, and are 
considered in the interpretation of thetest  results  in  the  same  way  as  animals  
that  died  on  test.  The method allows for the determination of an LD50 value only 
when at least two doses result in mortality higher than 0% and lower than 100%. 
PRINCIPLE:  
It is the principle of the test that based on a stepwise procedure with the use of 
a minimum  number  of  animals  per  step,  sufficient  information  is  obtained  on   
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the  acute toxicity  of  the  test  substance  to  enable  its  classification.  The 
substance is administered orally to a group of experimental animals at one of the 
defined doses.  The substance is tested using a stepwise procedure, each step using 
three animals of a single sex. Absence or presence of compound-related mortality of 
the animals dosed at one step will determine the next step, i.e.; − no further testing is 
needed − dosing of three additional animals with the same dose − dosing of three 
additional animals at the next higher or the next lower dose level. The method will 
enable a judgment with respect to classifying the test substance to one of a series of 
toxicity classes.   
METHODOLOGY   
Selection of animal species:  
The preferred rodent species is rat, although other rodent species may be used.  
Healthy  young  adult  animals  of  commonly  used  laboratory  strain Swiss albino 
is used .  Females should be nulliparous and non-pregnant.  Each animal at the 
commencement of its dosing should be between 8 and 12 weeks old and its weight 
should fall in an interval within±20 % of the mean weight of the animals.   
Housing and feeding conditions:   
  The  temperature  in  the  experimental  animal  room  should  be  22ºC  (+3ºC). 
Although  the  relative  humidity  should  be  at  least  30%  and  preferably  not   
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exceed  70% other than during room cleaning the aim should be 50-60%. Lighting  
should be artificial, the sequence being 12 hrs  light, 12 hrs dark. For feeding, 
conventional laboratory diets may be used with an unlimited supply of drinking 
water. Animals may be grouped and tagged by dose, but the number of animals per 
cage must not interfere with clear observations of each animal.   
Preparation of animals:   
  The animals are randomly selected, marked to permit individual identification, and 
kept in their cages for at least 7 days prior to dosing to allow for acclimatization to 
the laboratory conditions.  
Observation done: 
Group Day 
Body weight Normal 
Assessments of posture Normal 
Signs of Convulsion 
Limb paralysis 
Absence of sign (-) 
Body tone Normal 
Lacrimation Absence 
Salivation Absence 
Change in skin color No significant colour change 
Piloerection Normal 
Defecation Normal 
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Sensitivity response Normal 
Locomotion Normal 
Muscle gripness Normal 
Rearing Mild 
Urination Normal 
 
 
 
1.Alertness 2.Aggressiveness 3. Pile erection 4. Grooming   5.Gripping   6. Touch 
Response  7. Decreased Motor Activity   8.Tremors 9 Convulsions 10. Muscle Spasm 
11. Catatonia 12.Musclerelaxant 13.Hypnosis 14.Analgesia15.Lacrimation 
16. Exophthalmos 17. Diarrhea   18. Writhing   19 Respiration   20.  Mortality 
 
 
 
 
 
 
Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
2000 + - - - - + - - - - - - - - - - - - - - 
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Acute toxicity: 
In the acute toxicity study, the rats were treated with different concentration 
of shoot extract of Vediyuppu chendooram from the range of 5mg/kg to 2000mg/kg 
which did not produce signs of toxicity, behavioral changes, and mortality in the test 
groups as compared to the controls when observed during 14 days of the acute 
toxicity experimental period. These results showed that a single oral dose of the 
extract showed no mortality of these rats even under higher dosage levels indicating 
the high margin of safety of this extract. In acute toxicity test the extract of 
Vediyuppu chendooram was found to be non toxic at the dose level of 2000mg/ kg 
bodyweight.
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Sub-Acute toxicity test  
The dose selected for the sub acute toxicity study was 100mg, 
200mg/kg of  Vediyuppu chendooram. All the animals were free of 
intoxicating signs throughout the dosing period of 28 days. No physical 
changes were observed throughout the dosing period. No mortality was 
observed during the whole experiment. No abnormal deviations were 
observed. No significant changes were observed in the values of different 
parameters studied when compared with controls and values obtained were 
within normal biological and laboratory limits. The weights of organs 
recorded did not show any significant differences in the treatment and the 
control group indicating that Vediyuppu chendooram was not toxic to 
kidney, liver and spleen There was no significant changes were observed in 
hemoglobin (Hb), red blood cell (RBC), white blood cell (WBC), packed 
cell volume (PCV), Erythrocyte sedimentation rate (ESR) in all the treated 
groups as compared to respective control groups. Histopathology studies 
were carried out on liver, kidney and spleen and recorded 
SUB ACUTE TOXICITY REPORTS 
Vediyuppu chendooram 100 mg/kg 
HAEMOTOLOGY 
CBC 
WBC    :   10,000 cells/cumm 
Differential Count 
NEUTROPHILLS  : 10% 
LYMPHOCYTES  : 89 % 
EOSINOPHILS  : 01 % 
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MONOCYTES  : 00 % 
RBC    : 8.78 millions/cumm 
HB    : 16.0 gms%  
PCV    : 50.3 % 
MCV    : 57.3 fL 
MCH    : 18.2 pg  
MCHC   : 31.8 Grams/dl  
PLATELET   : 4.8 Lakhs/cumm 
    BIOCHEMISTRY 
Blood sugar   :  89  mg/dl 
BUN    :  50.9 mg/dl 
Creatinine   :  0.9  mg/dl 
SGOT   :  82  U/L 
SGPT    :  59  U/L 
ALP    :  140    U/L 
T.Protein   :  8.0  grams/dl 
Albumin   :  3.9  grams/dl 
LIPID PROFILE 
T. Cholesterol  :  105  mg/dl 
Triglycerides  :  68  mg/dl 
HDL    :  22  mg/dl 
LDL    :  69.4  mg/dl 
VLDL   :  13.6  mg/dl 
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Ratio 1(T.CHO/HDL)     :  4.77 
Ratio 2(LDL/HDL) :  3.1 
 
Histopathological report 
          Kidney   Liver    Spleen 
       
 
Vediyuppu chendooram 200 mg/kg 
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HAEMOTOLOGY 
CBC 
WBC    :   5,200 cells/cumm 
Differential Count 
NEUTROPHILLS  : 10% 
LYMPHOCYTES  : 89 % 
EOSINOPHILS  : 01 % 
MONOCYTES  : 00 % 
RBC    : 8.98 millions/cumm 
HB    : 16.9 gms%  
PCV    : 53.6 % 
MCV    : 59.7 Fl 
MCH    : 18.8 pg  
MCHC   : 31.5 Grams/dl  
PLATELET   : 7.20 Lakhs/cumm 
BIOCHEMISTRY 
Blood sugar   :  90  mg/dl 
BUN    :  52.8 mg/dl 
Creatinine   :  0.9  mg/dl 
SGOT   :  72  U/L 
SGPT    :  49  U/L 
ALP    :  135    U/L 
T.Protein   :  8.1  grams/dl 
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Albumin   :  3.1  grams/dl 
LIPID PROFILE 
T. Cholesterol  :  112  mg/dTriglycerides  :  69  mg/dl 
HDL    :  26  mg/dl 
LDL    :  72.2  mg/dl 
VLDL   :  13.8  mg/dl 
Ratio 1(T.CHO/HDL)     :  4.30 
Ratio 2(LDL/HDL) :  2.77 
 
 
 
        Kidney      Liver    Spleen 
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ANTI UROLITHIASIS ACTIVITY 
 
Stone induction⎯Kidney stones were induced by 0.75% of ethylene glycol 
in drinking water for 28 days ad libitum. After 28 days induction, the 
animals were used for the study 
Experimental design: 
 
In the experiment a total of 24 rats (6 normal rats, 18 urolithic rats) 
were used. The rats were divided into 4 groups of 6 rats each. Group I (Gr 
I)-Normal control rats; Group II (Gr II)-Urolithic rats, (Gr III)-Urolithic rats 
given Vediyuppu chendooram (200mg/kg, p.o.for 28 days) and (Gr IV)-
Urolithic rats given Vediyuppu chendooram (400mg/kg, p.o.for 28 days). At 
the end of 28 days, the animals were housed in metabolic cages and 
collected urine after 24 h.  
 
Biochemical assays 
The urine collected after 24 h was subjected to analyze calcium 
1
, 
oxalate 
2
, uric acid 
3,
, citrate 
4
,  
Groups Treatment 
Group I Normal Control 
Group II Urolithiasis rats- 0.75% of ethylene glycol 
for 28 days 
Group III Urolithiasis rats +  Vediyuppu chendooram 
200mg/kg for 28 days 
Group V Urolithiasis rats +  Vediyuppu chendooram 
400mg/kg for 28 days 
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Effect of Vediyuppu chendooram on ethylene glycol induced 
urothiasis activity in rats 
 
Biochemical 
Assays 
Gr-I Gr-II Gr-III Gr-IV 
Calcium 0.82±0.07 2.66±0.15
a
 1.60±0.14
b
 *** 1.14±0.08 b *** 
Oxalate 0.62±0.08 4.50±0.64 
a
 2.70±0.50  
b
 * 2.05±0.06 
b
 ** 
Uric acid 0.82±0.04 2.75±0.30 
a
 2.20±0.37 
a
* 1.42±0.25 
b
 * 
Citrate 2.42±0.20 0.76±0.05 
a
 1.27±0.14 
a
*** 0.97±0.08
a
*** 
  
Calcium, oxalate, citrate, uric acid, mg/24 h urine. Superscript letters represent P 
<0.05 (Tukey’s test). a As compared with group I, b As compared with group II.*P<0.05, 
**P <0.01, ***P<0.001.  
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Histopathology: 
Group I- Kidney of control rats showing normal cellular structure. H and E × 100 
Group II- Kidney of ethylene glycol induced urolithic rats showing magnified view of 
calcium oxalate stone with highly refractive crystal deposits 
Group III- Vedippu Chenduram 200 mg/kg treated rats showing near normal renal 
structure. H and E × 100. 
 
Group IV- Vedippu Chenduram 400 mg/kg treated rats showing  normal renal 
architecture. H and E × 100 
 
 
           
 
           
 
                                                                Group 1: 
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ANNEXURE – VI 
BIO STATISTICAL 
ANALYSIS 
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BIO STATISTICAL ANALYSIS 
CLINICAL PROGNOSIS 
Treatment for Kalladaippu: 
The most popular non parametric statistical tool, namely, McNemar Test analysis 
has been employed to analyses the effectiveness with the help of a hypothesis. 
 
S. 
No 
Signs&Symptoms Before Treatment After Treatment 
n% n% 
1. Flank pain 40(100) 9(22.5)** 
2. Nausea 3(7.5) 1(2.5)* 
3. Vomiting 1(2.5) 0(0)* 
4. Burning Micturition 20(50) 5(12.5)** 
5. Dysuria 8(20) 2(5)* 
6. Retention 1(2.5) 0(0)* 
7. Hematuria 3(7.5) 0(0)* 
McNemat test, C.I: 95%,  *P<0.05; **P<0.01 
Software: spss17 version 
Number of cases: 40 
Inference:  
Since the p value is significant in all symptoms. So there is significant reducing of 
symptoms among the patients for the treatment of Kalladaippu. Hence it is concluded that 
the treatment was effective and significant. 
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Treatment for Kalladaippu: 
The most popular non parametric statistical tool, namely, McNemar Test analysis 
has been employed to analyses the effectiveness with the help of a hypothesis. 
 
DISTRIBUTION OF CALCULI BASED ON LOCATION 
 
S. 
No 
Side Before Treatment After Treatment 
n% n% 
1. Rt – Kidney 13(32.5) 10(25)* 
2. Lt – Kidney 5(12.5) 1(2.5)* 
3. Bilateral 20(50) 14(35)* 
4. Ureteral 2(2) 1(2.5) * 
McNemat test, C.I: 95%,  *P<0.05; **P<0.01 
Software: spss17 version 
Number of cases: 40 
Inference:  
Since the p value is significant in all sides. So there is a significant changes in 
distribution of calculi based on location. Hence it is concluded that the treatment was 
effective and significant. 
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CONSENT FORM 
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ANNEXURE - VII 
GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
CLINICAL STUDY ON “VEDIYUPPU CHENDOORAM” IN THE TREATMENT 
OF 
“KALLADAIPPU” (UROLITHIASIS) 
 
 INFORMED CONSENT FORM 
 
“I have read the foregoing information. I have had the opportunity to ask 
questions about it and any questions I have asked have been answered to my satisfaction. 
            I   consent voluntarily to participate in this study and understand that I have the   
right to withdraw from the study at any time without in any way it affecting my further 
medical care”. 
"I have received a copy of the information sheet/consent form". 
Date:    
Station:                                                                                  
Signature of participant:  
 
Signature of the Guide:     Signature of the Investigator:   
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-  
 
                       ¸øÄ¨¼ôÒ வெடியுப்பு வெந்தூரம்  
 
´ôÒ¾ø ÀÊÅõ 
 
¬öÅ¡ÇÃ¡ø º¡ýÈÇ¢ì¸ôÀð¼Ð 
    ¿¡ý þó¾ ¬ö× ÌÈ¢ò¾ «¨ÉòÐ Å¢ÀÃí¸¨ÇÔõ §¿¡Â¡Ç¢ìÌ ÒÃ¢Ôõ Å¨¸Â¢ø 
±ÎòÐ¨Ãò§¾ý ±É ¯Ú¾¢ÂÇ¢ì¸¢§Èý. 
§¾¾¢:       ¨¸¦Â¡ôÀõ: 
þ¼õ:       ¦ÀÂ÷     : 
§¿¡Â¡Ç¢Â¢ý ´ôÒ¾ø 
±ýÉ¢¼õ þó¾ ÁÕòÐÅ ¬öÅ¢ý ¸¡Ã½ò¨¾Ôõ, ÁÕó¾¢ý ¾ý¨Á ÁüÚõ 
ÁÕòÐÅ ÅÆ¢Ó¨È ÀüÈ¢Ôõ, ¦¾¡¼÷óÐ ±ÉÐ ¯¼ø þÂì¸ò¨¾ ¸ñ¸¡½¢ì¸×õ, 
«¾¨É À¡Ð¸¡ì¸×õ ÀÂýÀÎõ ÁÕòÐÅ ¬ö×ìÜ¼ ÀÃ¢§º¡¾¨É¸û ÀüÈ¢ ¾¢Õô¾¢ 
«Ç¢ìÌõ Å¨¸Â¢ø ¬ö× ÁÕòÐÅÃ¡ø Å¢Çì¸¢ì ÜÈôÀð¼Ð. 
¿¡ý þó¾ ÁÕòÐÅ ¬öÅ¢ý §À¡Ð, ¸¡Ã½õ ±Ð×õ ÜÈ¡Áø, ±ô¦À¡ØÐ 
§ÅñÎÁ¡É¡Öõ þó¾ ¬öÅ¢Ä¢ÕóÐ ±ý¨É Å¢ÎÅ¢òÐ ¦¸¡ûÙõ ¯Ã¢¨Á¨Â 
¦¾Ã¢ó¾¢Õì¸¢ý§Èý. ¿¡ý ±ýÛ¨¼Â Í¾ó¾¢ÃÁ¡¸ §¾÷× ¦ºöÔõ ¯Ã¢¨Á¨Âì ¦¸¡ñÎ 
¸øÄ¨¼ôÒ §¿¡öì¸¡É               ÁÕó¾¢ý ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ 
ÁÕòÐÅ ¬öÅ¢üÌ ±ý¨É ¯ðÀÎò¾ ´ôÒ¾ø «Ç¢ì¸¢§Èý. 
 
§¾¾¢ :        ¨¸¦Â¡ôÀõ : 
þ¼õ :        ¦ÀÂ÷          : 
 
§¾¾¢  :        º¡ðº¢ì¸¡Ã÷ ¨¸¦Â¡ôÀõ : 
þ¼õ  :       ¦ÀÂ÷     :                                                                   
¯È×Ó¨È : 
 
Ð¨Èò¾¨ÄÅ÷ ¨¸¦Â¡ôÀõ :      ¨¸¦Â¡ôÀõ:         
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ANNEXURE - VIII 
CASE SHEET PROFORMA FOR KALLADAIPPU  
GOVT.SIDDHA MEDICAL COLLEGE&HOSPITAL, CHENNAI-106 
 POST GRADUATE DEPARTMENT BRANCH –I MARUTHUVAM 
Duration: 2014-2016 
 
OP No / IP No  :    Occupation  : 
Ward No  :    Income  : 
Bed No  :    Nationality  : 
Name   :    Religion  : 
Age   :    D.O.A   : 
Sex   :    D.O.D   : 
Address  :    Diagnosis  : 
 
 
 
1. Complaints and duration  : 
 
2. History of present illness  : 
 
3. History of past illness  : 
 
4. Personal history   : 
 
5. Occupational history  : 
 
6. Menstrual history   : 
 
7. Personal Habits   : Veg/non veg/smoker/Alcoholic/Tobacco chewer 
 
8. Family History   : 
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GENERAL EXAMINATION  
Patient consciousness   : 
Body Built    : 
Nourishment    : 
Anemia    : 
Jaundice    : 
Cyanosis    : 
Clubbing    : 
JVP     : 
Tracheal deviation   : 
Pedal oedema    : 
Lymph adenopathy   : 
 
VITAL SIGNS 
Body Temp    : 
Pulse     : 
Respiratory rate   : 
Blood Pressure   : 
Weight    : 
 
SIDDHA ASPECT 
NILAM 
Kurinji                                               : 
Mullai                                               : 
Marutham                                         : 
Neithal                                              : 
Palai                                                  : 
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PARUVA KALAM 
Kaar   : 
Koothir  : 
Munpani  : 
Pinpani  : 
Elavenil  : 
Muduenil  : 
 
YAAKKAI (Udal) 
Vatham                       : 
Pitham                        : 
Kabham                      : 
Kalappu                      : 
 
GUNAM 
Saththuvam                : 
Rajotham                    : 
Thamasam                  : 
 
PORI/PULANGAL 
(SENSORY ORGANS) 
Mei –Sensation   : 
Vaai – Taste    : 
Kan – Vision     : 
Mooku - Smell    : 
Sevi – Hearing   : 
 
. 
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KANMENTHRIYAM/KANNMA VIDAYAM [MOTOR ORGANS] 
Kai- Dhaanam    : 
Kaal-Kamanam   : 
Vaai-Vasanam   : 
Eruvaai- Visarkkam   : 
Karuvaai-Aanantham   : 
UTHKAAYA ATHAKAAYAM 
Puyam[forearm]   : 
Sayam[arm]    : 
Kaal[leg]    : 
Paaatham[feet]   : 
UYIR THATHUKKAL 
 
A.VATHAM 
 Piranan   : 
 Abanan   : 
 Viyanan   : 
 Udanan   : 
 Samanan   : 
 Nagan    : 
 Koorman   : 
 Kirukaran   : 
Devathathan   : 
Thananjeyan   : 
B.PITHAM 
Anar pitham   : 
Ranjaga pitham  : 
Saathaga pitham  : 
Pirrasaga pitham  : 
Alosaga pitham  : 
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C.KAPAM 
Avalambagam   : 
Kilethagam   :  
Pothagam   : 
Tharpagam   : 
Santhigam   : 
 
UDALTHAATHUKKAL 
Saaram   : 
Senner    : 
Oon    : 
Kozhuppu   : 
Enbu    : 
Moolai    : 
Sukkilam/Suronitham  : 
 
ENVAGAI THERVUGAL 
1.Naa    : 
2.Niram   : 
3.Mozhi   : 
4.Vizhi   : 
5.Sparisam   : 
6.Malam   : 
7.Moothiram 
a)Neer Kuri  : 
 b)Nei Kuri  : 
8.Naadi   : 
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MALAM 
 Niram    : 
 Edai    : 
 Erugal    : 
 Elagal    : 
MOOTHIRAM 
 1.Neerkuri 
  Niram   : 
  Manam  : 
  Edai   : 
  Nurai   : 
  Enjal   : 
 2.Neikuri 
 
MODERN ASPECT 
 
   Sytemic Examination  
 Inspection   : 
 Palpation   : 
                    Renal angle                     : 
                    Tenderness                      : Present/Absent  
                    Radiation                         :      
 Percussion   : 
 Auscultation   : 
 
     Others Systems  
 Cardio Vascular System : 
 Respiratory system  : 
 Central nervous system : 
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CLINICAL SIGN AND SYMPTOMS OF KALLADAIPPU 
 
 
S.No 
 
Symptoms 
 
Before 
Treatment 
After Treatment 
10
th
 
day 
20
th
 
day 
30
th
 
day 
40
th
 
day 
1 Pain 
 Site 
 Radiation 
 Character 
     
2 Nausea      
3 Vomiting      
4 Burning 
Micturition 
     
5 Dysuria      
6 Oliguria      
7 Haematuria      
8 Retention      
9 Fever      
10 Frequency of 
Micturition 
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INVESTIGATION 
      1. BLOOD 
  TC, DC, ESR 
  Bleeding time, Clotting time 
  Blood sugar 
  Blood urea 
  Serum cholesterol 
Serum calcium  
  VDRL 
 
      2. URINE 
    Colour 
  Turbidity 
  Albumin 
  Sugar 
  Deposits 
 Epithelial cells 
 RBC’s 
 Pus cells 
Casts 
Specific gravity 
Urine culture and sensitivity 
       
      3. USG Abdomen and Pelvis 
 
      4. X-Ray KUB 
 
TRIAL DRUG: veddiyuppu chendooram 
 
Dose: 130- 260  mg, bd. 
Adjuvant : mullangi kizhangu chaaru. 
Duration of Treatment: 48 days 
Pathiam (Do’s and Don’ts) 
 
Prognosis 
 
 
Medical Officer Signature:       HOD 
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